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ABSTRACT 
 
Human T-cell leukemia virus type 1 (HTLV-1) establishes a lifelong persistent 
infection in humans. Approximately 3% of the infected individuals will develop adult 
T-cell leukemia/lymphoma (ATLL), an aggressive malignancy of mature CD4+ T-
cells. The viral protein Tax plays a major role in HTLV-1 pathogenicity by activating 
the NF-κB pathway. Tax activates both the canonical and non-canonical NF-κB 
pathways, promoting NF-κB translocation to the nucleus and transcription of genes 
that favour T-cell proliferation and survival. Our previous studies showed that the 
p13 protein of HTLV-1 enhances mitochondrial ROS production, resulting in 
activation of normal T-cells. ROS constitute a homeostatic rheostat that controls the 
activity of several key pathways, including the NF-κB pathway. Thus, we 
hypothesized that the effects of p13 on ROS production could affect the activation of 
the NF-κB pathway by Tax in primary T-cells. 
The work described in the present thesis was aimed at testing the hypothesis that Tax 
and p13 might act in concert to activate the NF-κB signal transduction pathway in 
primary T-cells. To this end, we optimized a transfection protocol for primary T-cells 
using an innovative approach based on the electroporation of in vitro-transcribed 
RNA. Activation of the NF-κB pathway was then analysed by measuring expression 
of the NF-κB target genes CD25 and 4-1BB. 
Results showed that the co-transfection of Tax and p13 resulted in a synergistic 
activation of the NF-κB pathway in primary T-cells measured as an increase in the 
expression levels of both CD25 and 4-1BB. In addition to being a transcriptional 
target of NF-κB, CD25 is also an early marker of T-cell activation. To further test the 
effects of Tax and p13 on cell activation, we measured CD38 expression by flow 
cytometry. Jurkat T-cells, which exhibit a constitutively activated CD38 positive 
phenotype, were used as a control. Results of this analysis confirmed the synergy of 
Tax and p13, although the effect was not so prominent as that observed for the CD25 
marker, suggesting that, within the time frame of our experiments, Tax and p13 drove 
T-cells to an early-intermediate stage of activation. 
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Taken together, these findings suggest that, in contrast to the well-established role of 
Tax as an activator of the NF-κB pathway in tumor cell lines, in the context of normal 
T-cells, the induction of NF-κB target genes requires the concerted action of Tax and 
p13.  
Current studies are aimed at verifying the ROS-dependence of this effect and testing 
the functional interaction of Tax and p13 in the context of the complete HTLV-1 
genome using wild type HTLV-1 and a p13-knock-out HTLV-1 molecular clone. 
These experiments will be carried out in primary T-cells as well as in dendritic cells, 
which have recently emerged as an important target of the virus in vivo.  
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RIASSUNTO  
 
Il virus T-linfotropico umano di tipo 1 (HTLV-1) stabilisce un'infezione persistente 
negli uomini. Circa il 3% degli individui infettati sviluppa la leucemia/linfoma a 
cellule T dell'adulto (ATLL), un'aggressiva neoplasia a carico dei linfociti T CD4+ 
maturi. L'attivazione della via di segnale di NF-κB mediata dalla proteina virale Tax è 
un evento cruciale nella patogenesi dell’infezione da HTLV-1. Tax attiva entrambe le 
vie di segnale di NF-κB, canonica e non-canonica, promuovendo la traslocazione 
nucleare di NF-κB e la trascrizione di geni che favoriscono la proliferazione e la 
sopravvivenza delle cellule T. I nostri studi precedenti hanno rivelato che la proteina 
virale p13 favorisce la produzione di specie reattive dell'ossigeno (ROS) a livello 
mitocondriale, causando l'attivazione di cellule T normali. I ROS possono essere 
paragonati ad un reostato che controlla l'attività di diverse vie di trasduzione del 
segnale, inclusa la via di NF-κB. 
Lo scopo primario di questa tesi è stato quindi di verificare l'ipotesi che Tax e p13 
potessero attivare sinergicamente la via di trasduzione del segnale di NF-κB in cellule 
T normali. A tal fine, è stato ottimizzato un protocollo di trasfezione di cellule T 
primarie utilizzando un approccio innovativo basato sull'elettroporazione di RNA 
trascritto in vitro. L'attivazione della via di NF-κB è stata analizzata misurando 
l'espressione dei geni target di NF-κB CD25, mediante analisi citofluorimetrica, e 4-
1BB, mediante RT-PCR quantitativa. 
I risultati ottenuti hanno mostrato che in cellule T normali, la co-trasfezione di Tax e 
p13 causa l'attivazione sinergica della via di NF-κB misurata come incremento dei 
livelli di espressione di entrambi i geni target. Oltre ad essere un target trascrizionale 
di NF-κB, il CD25 è anche un marcatore precoce di attivazione di cellule T. Per 
verificare il possibile effetto di Tax e p13 sull'attivazione cellulare, abbiamo misurato 
mediante analisi citofluorimetrica l'espressione del CD38, un marcatore intermedio-
tardivo di attivazione. La linea T-cellulare leucemica Jurkat, caratterizzata da un 
fenotipo costitutivamente CD38 positivo, è stata utilizzata come controllo. I risultati 
di questa analisi hanno confermato la sinergia di Tax e p13, nonostante l'effetto 
sull’espressione del CD38 non fosse così prominente come quello osservato per il 
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CD25, suggerendo che, nel nostro contesto sperimentale, Tax e p13 spingano le 
cellule T in uno stadio precoce-intermedio di attivazione. 
In complesso questi risultati suggeriscono che, in contrasto con il ruolo ben stabilito 
di Tax nell'attivazione della via di NF-κB in linee cellulari tumorali, nel contesto 
delle cellule T normali, l'induzione dei geni target di NF-κB necessita l'azione 
sinergica di Tax e p13.  
Gli studi attualmente in corso sono volti a verificare la ROS-dipendenza dell'effetto 
sinergico di Tax e p13 sulla via di segnale di NF-κB. Inoltre, verificheremo la validità 
dell'interazione funzionale di Tax e p13 nel contesto del intero genoma di HTLV-1. A 
tal fine, paragoneremo l'attivazione della via di NF-κB indotta da un clone molecolare 
di HTLV-1 wild type, con quella indotta da un clone molecolare di HTLV-1 p13-
knock-out. Questi esperimenti verranno condotti in cellule T primarie ed in cellule 
dendritiche, che rappresentano il principale target infezione da HTLV-1 in vivo. 
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1. INTRODUCTION 
 
1.1 Human T-cell leukemia virus type 1: taxonomy, epidemiology and 
pathogenesis. 
Human T-cell leukemia virus type 1 (HTLV-1) was the first human retrovirus to be 
identified and is the only one with proven oncogenic properties (Poiesz et al., 1980; 
Hinuma et al., 1981). 
HTLV-1 belongs to the Retroviridae family, Oncovirinae sub-family, Deltaretrovirus 
genus, which also includes HTLV-2, -3, -4, simian T-Lymphotropic virus (STLV-1-
5), and bovine leukemia virus (BLV). STLV and BLV infections are associated with 
neoplastic diseases, while the pathogenicity of HTLV-2, -3, and -4 has not been 
clearly established (Araujo and Hall, 2004; Feuer and Green, 2005; Mahieux and 
Gessain, 2009). Deltaretroviruses are referred to as “complex” retroviruses. In fact, 
they present at the 3’ end of the genome, the so called “pX region” that encodes the 
regulatory proteins Tax and Rex and several accessory proteins. The oncogenic 
properties of Deltaretroviruses do not involve either the expression of a cell-derived 
viral oncogene (v-onc), or the activation of a cellular proto-oncogene (c-onc) through 
proviral integration, as in the case of acute and chronic transforming retroviruses, 
respectively. Instead, the oncogenicity of HLTV-1 is attributed mainly to the 
regulatory protein Tax (Paragraph 1.4.1). 
HTLV-1 infects about 20 million people worldwide and is endemic in South-Western 
Japan, Central Africa, Iran, the Caribbean Basin, Central and South America and the 
Melanesian Islands. Sporadic infections occur in Europe and North America. 
Transmission of the virus may occur in a “vertical” manner from mother to newborn, 
mainly through breastfeeding and in few cases perinatally, or “horizontally” through 
exchange of biological fluids (sexual contact and parenteral transmission) (Proietti et 
al., 2005).  
HTLV-1 is the causative agent of two distinct pathologies: adult T-cell 
leukemia/lymphoma (ATLL), an aggressive malignancy of mature CD4+ T-cells that 
is extremely refractory to current therapies (Uchiyama et al., 1977; Tsukasaki et al., 
2009), and tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM), 
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a demyelinating neurodegenerative disease (Gessain et al., 1985; Osame et al., 1986). 
The development of ATLL has been linked to the transmission through breast milk of 
infected mothers, whereas TSP/HAM is prevalent when the infection is transmitted to 
adults as in the case of transfusion of infected blood products (Uchiyama, 1997). 
HTLV-1 infection is also associated with a number of chronic inflammatory diseases 
such as uveitis (Mochizuki et al., 1992; Pinheiro, 1995), arthritis (Murphy et al., 
2004b; Yakova et al., 2005) and infective dermatitis (LaGrenade et al., 1990).  
The majority of HTLV-1-infected individuals remain asymptomatic throughout life; 
approximately 3% develop ATLL or TSP/HAM after a latency period of decades or 
several years, respectively (Kawano et al., 1985). In spite of over 30 years of study, 
the molecular mechanisms leading to ATLL or TSP/HAM development have not 
been fully clarified. 
HTLV-1 infection of peripheral blood mononuclear cells (PBMCs) leads to cell 
immortalization. After several months of culture, it is possible to detect mono- or 
oligoclonal provirus integration. This profile results from a selection process of one 
or few major clones that carry several genetic alterations and acquire the capability to 
grow in an interleukin-2 (IL-2)-independent manner. These cells usually show a 
CD3+ CD4+ IL-2R+ (IL-2 receptor, CD25), or, rarely, a CD3+ CD8+ IL-2R+ 
phenotype (Lairmore and Franchini, 2007).  
The dynamics of infection and immortalization observed in vitro recapitulate at least 
part of the natural history of ATLL in vivo. ATLL is classified into four clinical 
forms: acute, chronic, smouldering and lymphoma (Tsukasaki et al., 2009). In some 
cases the acute phase of ATLL is preceded by peripheral lymphocytosis with poly- or 
oligoclonal integration of the viral genome. Although acute ATLL was characterized 
by the presence of a dominant proliferating leukemic clone with monoclonal 
integration of the provirus (Lairmore and Franchini, 2007), a recent study based on 
massive sequencing of integration sites in ATLL patients and asymptomatic carriers 
revealed an oligoclonal pattern of integration of the virus, with a large number of 
unique insertion sites (Gillet et al., 2011). This oligoclonal pattern differs between 
ATLL patients and asymptomatic carriers, with ATLL patients characterized by 
proviral integration near activating epigenetic region, that expand more frequently 
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than in asymptomatic carriers, suggesting a negative selection that shapes the 
distribution of abundance of HTLV-1 clones in vivo. This negative selection is 
probably due to the cytotoxic T-cell (CTL) response to HTLV-1, and is stronger in 
asymptomatic carriers than in patients with ATLL (Gillet et al., 2011). ATLLs cells 
possess multi-lobulated nuclei and are called “flower cells”; they are usually CD3+ 
CD4+ CD8- CD25+ and frequently accumulate in peripheral blood as well as in 
lymphoid organs and skin. ATLL cells express very little, if any, viral protein and 
frequently carry defective proviral copies integrated in the host genome. The 
propagation and persistence of the infected cells in the host relies mainly on “mitotic 
transmission” of the integrated viral genome to daughter cells, rather than on de novo 
infection of new host cells (Overbaugh and Bangham, 2001).  
HTLV-1 infection is accompanied by a high frequency of Forkhead Box P3 positive 
(FoxP3+) T-cells (Chen et al., 2006; Kohno et al., 2005). FoxP3 is a marker of 
regulatory T cells (Treg), which play a critical role in suppressing the immune 
response. The frequency of FoxP3+ cells in the peripheral blood is especially high in 
patients with chronic ATLL. However, in ATLL, the FoxP3+ leukemic T-cell clones 
are distinct from the functional Treg population (Abe et al., 2008; Toulza et al., 
2009). The increased frequency of FoxP3+ cells in ATLL results from the HTLV-1-
mediated expression of the chemokine CCL22, which binds the CCR4 receptor on 
Treg cells, favouring their migration and survival. The FoxP3+ T cells suppress the 
growth of autologous ATLL clones, retarding the progression of ATLL; on the other 
hand, they suppress the host's CTL response, which normally limits HTLV-1 
replication and reduces the risk of HTLV-1-associated diseases (Toulza et al., 2010; 
Bangham and Toulza, 2011). 
One common feature of ATLL is hypercalcemia, which is due to the Tax-mediated 
transcriptional activation of a parathormone-like peptide. The prognosis of acute 
ATLL is extremely poor with an overall survival of a few months. 
TSP/HAM is characterized by a slowly progressive spastic paraparesis, associated 
with bladder dysfunction and sensory disorders (Rodgers, 1965). Parenchymal and 
perivascular infiltration of mononuclear cells occurs in the white and gray matter of 
the spinal cord, resulting in demyelization and fibrosis (Iwasaki, 1990). The presence 
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of infiltrating T-cells in the spinal cord lesions and of Tax-specific CTL in the 
cerebrospinal fluid and in the peripheral blood suggests that TSP/HAM might have an 
autoimmune basis (Osame, 2002; Johnson-Nauroth et al., 2006; Verdonck et al., 
2007). This hypothesis is consistent with the association between the human 
leukocyte antigen (HLA) haplotype and the risk of developing TSP/HAM (Jeffery et 
al., 1999; Barmak et al., 2003). 
 
1.2 Infection and virus propagation 
The HTLV-1 virion consists of a core that contains the viral-encoded enzymes 
(reverse transcriptase, integrase and protease) and the single-stranded diploid RNA 
genome surrounded by capsid and matrix proteins. A lipoproteic envelope, composed 
of a plasma membrane-derived lipid bilayer and the gp21 and gp46 envelope 
glycoproteins, surrounds the viral core (Figure 1) (Manel et al., 2005; Lairmore and 
Franchini, 2007). HTLV-1 presents a broad cell tropism in vitro (monocytes, 
microglial cells, epithelial cells, B- and T- lymphocytes), but it is mainly detected in 
CD4+ T-lymphocytes and dendritic cells of infected individuals (Manel et al., 2005; 
Macatonia et al., 1992). So far, three cellular receptors of HTLV-1 have been 
identified: the glucose transporter GLUT-1, heparan sulphate proteoglycan (HSPG), 
and neuropilin-1. Current models suggest that the virus may first contact HSPG on 
the cell surface, and then form complexes with neuropilin-1 through the viral 
envelope protein (Jones et al., 2005; Lambert et al., 2009). Afterwards, the interaction 
between the viral envelope protein gp46 and GLUT-1 would favour membrane fusion 
and entry into the cell (Manel et al., 2003). Consequently, glucose consumption in the 
infected target cell is inhibited and extracellular milieu acidification is reduced, 
possibly causing metabolic alterations in the infected cells (Manel et al., 2003; Manel 
et al., 2005). The gp46-GLUT-1 interaction allows the envelope protein gp21 to 
mediate cellular membrane fusion with the formation of the virological synapse. The 
virological synapse is an organized contact area whose assembly results from the 
polarization of the cytoskeleton of the infected cell and the accumulation of HTLV-1 
core complexes and genome at the cell junction. The virion components are then 
transferred to the uninfected cell as enveloped particles (Ikagura et al., 2003; 
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Majorovits et al., 2008). Tax is also involved in the formation of the virological 
synapse: it localizes in the contact region between infected and target cells 
(Nejmeddine et al., 2005) and enhances the microtubule-organizing centre (MTOC) 
formation by stimulating the CREB pathway (Nejmeddine et al., 2005; Nejmeddine 
et al., 2009). The MTOC polarization is induced by the engagement of intracellular 
adhesion molecule-1 (ICAM-1) by its cognate receptor lymphocyte function 
associated antigen-1 (LFA-1) (Barnard et al., 2005), and activation of the Ras-MEK-
ERK pathway (Nejmeddine et al., 2009). 
In addition to the formation of the virological sinapse, two other mechanisms have 
been proposed to be involved in the cell-to-cell transmission of HTLV-1. The first 
involves the storage of viral particles from HTLV-1 infected cells in extracellular 
biofilm-like structures, composed of collagen, agrin, and linker-proteins. When 
infected cells attach to uninfected cells, those structures are rapidly transferred to the 
surface of the target cells, favouring infection (Pais-Correia et al., 2010). Another 
mechanism of virus spread involves the activity of the viral accessory protein p8. p8 
enhances T-cell contact by interacting with LFA-1 and ICAM-1 and mediates 
formation of intracellular conduits among T-cells, through which virions may be 
transmitted (Van Prooyen et al., 2010). All these mechanisms are consistent with the 
fact that cell-free HTLV-1 particles are usually undetectable in the serum of HTLV-1 
infected subjects and cell-free blood products are not infectious (Fan et al., 1992; 
Derse et al., 2001). 
A notable exception to the cell-to-cell mode of viral transmission is represented by 
dendritic cells, which can be infected by cell-free HTLV-1 virions (Jones et al., 
2008). HTLV-1-positive dendritic cells have been detected in the peripheral blood of 
infected individuals (Macatonia et al., 1992). Moreover, HTLV-1-exposed dendritic 
cells are an efficient viral vector for autologous primary CD4+ T-cells. The most 
important antigen receptor mediating HTLV-1 binding, transmission, and cell-free 
infection in dendritic cells is the DC-specific intercellular adhesion molecule-3 
(ICAM-3)-grabbing nonintegrin (DC-SIGN) (Jain et al., 2009). Heparan sulfate 
proteoglycans and neuropilin-1 also contribute to transmission of the virus to 
dendritic cells. DC-mediated transmission of HTLV-1 results in long-term productive 
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infection and interleukin-2-independent transformation of the CD4+ T-cells (Jones et 
al., 2008). 
After virus entry into the target cell, the viral genome is reverse-transcribed by the 
viral reverse transcriptase (RT), producing an RNA-DNA hybrid. The ribonuclease H 
(RNAse H) component of viral RT degrades the RNA strand, while the DNA strand 
is used as a template by RT, which also has DNA-polymerase-DNA-dependent 
activity, to synthesize a complementary DNA strand. The double-stranded DNA 
circularizes and transfers to the nucleus, where it integrates randomly in the host 
genome. Integration is mediated by the viral enzyme integrase and by the long 
terminal repeats (LTRs) located at both ends of the viral genome. Viral genes are then 
transcribed and translated by the cellular machinery. Virion assembly occurs through 
the interactions between the nucleocapsid and the genomic RNA, and the matrix and 
the host plasma membrane. Viral particles incorporate two copies of the single 
stranded RNA genome along with tRNA, RT, protease and integrase. 
 
 
 
 
Figure 1. Schematic representation of the HTLV-1 virion (Adapted from Le Blanc et al., 2001). 
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1.3 HTLV-I genetic organization 
The genome of HTLV-1 reflects the basic structure of the Deltaretrovirus genus 
(Figure 2). At the 5’ and 3’ ends are located the long terminal repeat (LTR) 
sequences. The LTRs flank the partially overlapping open reading frames (ORFs) of 
the gag, pro, pol and env genes that code for enzymes and structural proteins of 
mature viral particles. The region between the end of the env gene and the 3’ LTR is 
termed the pX region and contains four major partially overlapping ORFs, termed x-I 
through x-IV, coding for regulatory and accessory proteins (Figure 2A). The minus 
strand of HTLV-1 also contains an ORF located in the pX region (antisense 
orientation) (Larocca et al., 1989) which codes for the HTLV-1 bZIP factor protein 
(HBZ) (Figure 2B) (Gaudray et al., 2002). Expression of the highly condensed 
HTLV-1 genetic information is achieved through different mechanisms: (i) ribosomal 
frameshifting, which generates a Gag-Pro-Pol polyprotein from the full-length 
transcript; (ii) alternative splicing, which produces distinct mRNAs coding for the 
Env and pX region genes; and (iii) polycistronic translation, which produces the Tax 
and Rex proteins from the same mRNA. Minus strand transcription generates at least 
two different mRNAs encoding two isoforms of the HBZ protein. 
The HTLV-1 transcripts can be grouped in four major classes (Figure 2A and B): 
a) plus strand unspliced mRNA (US), coding for Gag-Pro-Pol, and used as genomic 
RNA; 
b) plus strand singly-spliced mRNAs (SS), coding for the envelope glycoproteins 
(Env) and for the accessory proteins p21rex, p12 (p8) and p13; 
c) plus strand doubly-spliced mRNAs (DS), coding for the regulatory proteins p40 
(Tax) and p27 (Rex), and for the regulatory/accessory protein p30/tof; 
d) minus strand mRNAs coding for HBZ proteins. 
A recent study carried out on primary cells from infected patients and cells 
transfected with HTLV-1 molecular clone, indicated a two-phase pattern of gene 
expression, with the tax/rex mRNA preceding expression of other transcripts (Rende 
et al., 2011). This study also showed that over 90% of the HBZ mRNAs are localized 
in the nuclear compartment, suggesting their role as a nuclear non-coding transcripts 
(Paragraph 1.4.7).  
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Figure 2. Organization and expression of the HTLV-1 genome. A: The transcriptional map of plus-
strand mRNAs and proteins coded by each mRNA is shown. The numbers indicate the position of the 
splicing sites. Resulting exons are: 1 (1-119), 2 (4641-4831), 3 (6950-8493), B (6478-8493), C (6875-
8493) and E (4641-8493). mRNAs are named according to their exon composition. B: The 
transcriptional map of the minus-strand mRNAs and proteins coded by each mRNA is shown. The 
numbers indicate transcription start sites and splicing sites. Resulting exons are: hbz us (7222-4834) 
and hbz sp1 (8471-8315 and 6915-4834) (Rende et al., 2011). 
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1.3.1 Expression of structural proteins  
The full-length plus-strand US mRNA (8.6 kb) is packaged into virions as the 
genomic RNA and is also translated into the structural proteins (gag) and enzymes 
(protease and polymerase) of mature virus particles (Lairmore and Franchini, 2007). 
The gag gene codes for the 19 kDa matrix (MA), 24 kDa capsid (CA) and 15 kDa 
nucleocapsid (NC) structural proteins. p24-CA multimers form the inner core of the 
virion; p15-NC interacts with the genomic RNA inside the inner core of the virion; 
and p19-MA is involved in virus budding and assembly (Dorweiler et al., 2006; 
Heidecker et al., 2007), and has a role in cell-to-cell transmission of the virus (Le 
Blanc et al., 1999; Hémonnot et al., 2006). The pro gene encodes the viral protease. 
The 5' portion of the pol gene encodes reverse transcriptase (RT) and integrase. These 
genes are translated as polyproteic precursors (Gag, Gag-Pro and Gag-Pro-Pol) 
generated through ribosomal frameshifting at the gag-pro and/or gag-pro-pol 
junction. The precursors are post-translationally myristylated at the N-terminus, an 
essential step for their insertion in the inner layer of the plasma membrane of the 
infected cell. After virion budding, the precursors are cleaved by the viral protease to 
generate the single mature polypeptides. 
The 4.2 kb SS mRNA codes for the env precursor, which is post-translationally 
modified by glycosylation and cleaved into the surface gp46 (SU) and transmembrane 
gp21 (TM) proteins.  
 
1.3.2 Expression of proteins coded by the pX region  
The pX region of the HTLV-1 genome contains at least four different partially 
overlapping open reading frames, termed x-I through x-IV, that code for non 
structural proteins of HTLV-1. As shown in Figure 2A, expression of the different pX 
region genes is accessed through alternative splicing and polycistronic translation. All 
these mRNAs contain exon 1, which is non coding.  
Singly spliced mRNAs code for the accessory proteins p13 (mRNA 1-C, translated 
from a start codon located in the x-II ORF), p12/p8 (mRNA 1-B, translated from a 
start codon in the x-I ORF) and p21rex (mRNA 1-3, translated from a start codon 
located in the x-III ORF) (Ciminale et al., 1992; Koralnik et al., 1992).  
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Two doubly spliced mRNAs contain exons 1 and 2, and different 3' exons. mRNA 1-
2-3 is a bicistronic transcript coding for the regulatory proteins Rex and Tax; Rex 
initiates at the first AUG in exon 2 and continues in the x-III ORF in exon 3, while 
Tax initiates at the second AUG and continues in the x-IV ORF in exon 3. The 1-2-B 
mRNA codes for the accessory/regulatory protein p30/tof, which is translated from 
the second start codon of exon 2 and continues in frame with the x-II ORF in exon B 
(Ciminale et al., 1992; Koralnik et al., 1992). 
 
1.3.3 Expression of proteins coded by the minus strand of HTLV-1  
The minus strand of HTLV-1 contains one ORF located in the pX region (antisense 
orientation) which generates two major transcripts, one spliced (hbz sp1) and the 
other unspliced (hbz us) (Cavanagh et al., 2006; Murata et al., 2006; Satou et al., 
2006). These transcripts code for two isoforms of HBZ protein that differ by seven 
amino acids at the N-terminus. Hbz sp1 has multiple transcriptional initiation sites in 
the U5 and R regions of the 3' LTR, whereas the hbz us transcript initiates within the 
tax gene (Figure 2B). Both hbz sp1 and hbz us are transcribed from TATA-less 
promoters (Yoshida et al., 2008). 
 
1.4 Functions of the non-structural proteins  
1.4.1 Tax 
Tax is a 353-amino acid 40-kDa phosphoprotein that transcriptionally controls the 
expression of viral genes and of a large number of cellular genes. Tax is 
predominantly a nuclear protein, although it can translocate to the cytoplasm. The 
following functional domains have been mapped in the Tax sequence (Boxus et al., 
2008): 
a) a nuclear localization signal (NLS) located in the N-terminal domain; 
b) a zinc finger region that overlaps with the NLS and is crucial for Tax's interaction 
with the CRE-binding/activating transcription factor (CREB/ATF) and the serum 
responsive factor (SRF); 
c) a kinase-inducible domain (KID) and a dimerization domain localized in the 
central region of Tax. The KID domain mediates the interaction with the kinase-
15 
 
inducible exchange (KIX) domain of the transcriptional co-activators CREB binding 
protein (CBP) and p300. 
d) A domain involved in the interaction of Tax with the transcriptional co-activator 
p300/CBP-associated factor (P/CAF), located in the C-terminal region of the protein. 
 
1.4.1.1 Effects of Tax on the CREB pathway 
Tax was initially described as an activator of LTR-directed transcription (Felber et 
al., 1985). Three Tax responsive elements (TRE), within the U3 region of the LTR, 
are sufficient to confer Tax responsiveness (Brady et al., 1987). The TRE elements 
are imperfectly conserved sequences of 21 nucleotides. Each element contains an 
octamer motif TGACG(T/A)(C/G)(T/A) flanked by a GC stretch at the 5' and 3' ends 
(Jeang et al., 1988). The octamer motif shares homology with the consensus cAMP-
responsive element (CRE) (5’-TGACGTCA-3’). Tax exhibits poor affinity for DNA 
and binds indirectly to the TRE element by interacting with members of the 
CREB/ATF family (Giam and Xu, 1989). These proteins share a common cluster of 
basic residues, allowing DNA binding, and a leucine zipper (b-Zip) domain involved 
in homo- and heterodimerization. Tax promotes formation of a Tax-CREB/ATF-TRE 
ternary complex by interacting with the b-Zip domain of CREB/ATF factors. Tax 
enhances the dimerization of CREB/ATF factors, increasing their affinity for the TRE 
(Wagner and Green, 1993; Anderson and Dynan, 1994; Perini et al., 1995; Yin and 
Gaynor, 1996), and further stabilizes the ternary complex through direct contact of 
the GC-rich flanking sequences (Kimzey and Dynan, 1998; Lundblad et al., 1998). 
Tax also recruits coactivators (CBP/p300 and P/CAF) to facilitate transcription 
initiation. The ability of Tax to dimerize is required for efficient ternary complex 
formation and for optimal transactivation (Jin and Jeang, 1997; Tie et al., 1996). 
Physiologically, the CREB-CBP/p300 interaction is controlled by CREB 
phosphorylation in response to different signal transduction pathways. Through its 
ability to bind both CREB and CBP/p300, Tax triggers CREB activation even in the 
absence of phosphorylation. In this way, viral gene transcription becomes 
independent from cellular signals. 
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Through its interactions with CREB/ATF proteins, Tax can both activate a variety of 
cellular genes, including interleukin 17 (IL-17) and c-fos (Dodon et al., 2004; 
Alexandre and Verrier, 1991) and repress the expression of other genes such as cyclin 
A, p53 and c-myb (Kibler and Jeang, 2001; Mulloy et al., 1998; Nicot et al.,2000). 
 
1.4.1.2 Effects of Tax on the NF-κB pathway 
The oncogenic properties of Tax have been ascribed, mostly, to its ability to activate 
NF-κB, a major survival pathway engaged by HTLV-1 infection (Saggioro et al., 
2009). The mammalian NF-κB proteins consist of five structurally related members: 
p65/RelA, RelB, c-Rel, NF-κB1 (p50/and its precursor p105) and NF-κB2 (p52/and 
its precursor p100) which form homo-heterodimers that regulate the expression of 
target genes bearing a NF-κB-responsive elements in their promoters (Hayden and 
Ghosh, 2012). In unstimulated cells, NF-κB dimers are sequestered in the cytoplasm 
by inhibitory proteins called IκBs (comprising p105, p100, IκBα, IκBβ, IκBγ, IκBζ, 
and Bcl-3) that mask the nuclear localization signal of NF-κB. Upon cell stimulation, 
IκB proteins are rapidly phosphorylated and degraded by the proteasome, and NF-κB 
translocates into the nucleus to regulate the expression of target genes coding for 
cytokines, chemokines, adhesion molecules, inhibitors of apoptosis, and other 
proteins (Hayden and Ghosh, 2012). 
Two main signalling pathways lead to NF-κB activation: the canonical (or classical) 
and the non-canonical (or alternative) pathways.  
The canonical NF-κB pathway is induced by a variety of innate and adaptive 
immunity mediators, such as pro-inflammatory cytokines (TNF-α, IL-1β), and 
engagement of Toll-like receptors (TLRs) and antigen receptors (TCR, BCR) (Pahl, 
1999; Bonizzi et al., 2004). The crucial step in the canonical NF-κB pathway is the 
activation of the IκB-kinase (IKK) complex, which consists of the two kinases, IKKα 
and IKKβ (Zandi et al., 1997), and of one regulatory subunit IKKγ, also known as 
NF-κB essential modulator (NEMO) (Yamaoka et al., 1998) (Figure 4A). Activated 
IKK phosphorylates IκBα on serines 32 and 36, triggering its ubiquitination and 
proteasomal degradation. This unmasks the DNA binding activity of the p50/RelA 
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dimer, and allows its translocation into the nucleus where it activates the transcription 
of target genes (Beinke and Ley., 2004) (Figure 4A). 
Tax intervenes at multiple levels to activate the canonical NF-κB pathway. In the 
cytoplasm, Tax directly binds to NEMO and recruits the IKK complex to the 
perinuclear compartment, where it is phosphorylated and activated (Harhaj and Sun, 
1999; Jin et al., 1999; Xiao et al., 2000). Tax also activates kinases upstream to the 
IKK complex, including MAPK/ERK kinase kinase 1 (MEKK1) and TGF-β 
activating kinase 1 (TAK1) (Yin et al., 1998; Wu and Sun, 2007), thus enhancing 
IKKα and IKKβ phosphorylation, and IκBα and IκBβ degradation (Harhaj and Sun, 
1999; Jin et al., 1999). In addition, Tax binds IKKα and IKKβ and activates their 
kinase activity independently of the upstream kinases (Chu et al., 1998). The binding 
of Tax to IκBs also enhances their degradation independently of IKK phosphorylation 
(Hirai et al., 1994; Suzuki et al., 1995). Tax thus promotes IκBs degradation at 
multiple levels, allowing nuclear translocation of NF-κB independently of external 
stimuli. In the nucleus, Tax recruits RelA, CBP/p300 and PCAF (Bex et al., 1998; 
Bex and Gaynor, 1998) into discrete transcriptional hot spots termed Tax nuclear 
bodies, leading to NF-κB transcriptional activation (Semmes and Jeang, 1996; Bex et 
al., 1997). 
The non-canonical NF-κB pathway is important for secondary lymphoid organ 
development and homeostasis. It is induced by B-cell activating factor (BAFF) 
(Claudio et al., 2002), lymphotoxin β (LTβ) (Dejardin et al., 2002), and CD40 ligand 
(Coope et al., 2002; Xiao et al., 2001a). The crucial step in this pathway is the 
processing of p100 into p52 by IKKα, thus allowing p52 DNA binding in association 
with its partner RelB. The phosphorylation and activation of IKKα is mediated by the 
upstream NF-κB inducing kinase (NIK) (Figure 4B) (Xiao et al., 2001b; Xiao et al., 
2004). Interestingly, NIK can also induce long-term activation of the IKK complex 
and IκBα degradation, thus activating also the canonical NF-κB pathway (Zarnegar et 
al., 2008) (Figure 4A and B).  
The induction of the non-canonical pathway is a hallmark of NF-κB activation by 
HTLV-1 infection, because this arm of the pathway usually is not active in normal T 
cells (Xiao et al., 2001a). Tax induces the non-canonical NF-κB pathway by 
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promoting the processing of p100 to p52 (Xiao et al., 2006). Tax-mediated processing 
of p100 requires NEMO as an adaptor protein in the assembly of the Tax/IKK 
complexe, and is independent of the NIK kinase. In contrast to the canonical 
Tax/NEMO/IKK complex, which contains both the IKKα and β, the non-canonical 
complex contains only IKKα (Xiao et al., 2001b), which phosphorylates p100 leading 
to its processing to p52 (Qu et al., 2004). 
 
 
 
 
Figure 4. NF-кB activation: the canonical and non-canonical pathways. A:The stimuli that induce 
the canonical NF-кB pathway converge on the activation of the IKK complex, which consists of the 
two kinases, IKKα and IKKβ, and one regulatory subunit IKKγ/NEMO. The IKK complex 
phosphorylates IκBα, triggering its proteasomal degradation. This allows the translocation of NF-κB1 
(p50/RelA) in the nucleus, where it activates the transcription of target genes. B: The crucial step of 
the non-canonical NF-кB pathway is the processing of p100 into p52 mediated by IKKα, thus allowing 
NF-кB2 (p52/RelB) DNA binding. The phosphorylation and activation of IKKα is mediated by the 
upstream NIK kinase, which also induces IκBα degradation, thus activating the canonical NF-κB 
pathway (Adapted from Morgan and Liu., 2011).  
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Almost all steps of the NF-κB pathway can be terminated through feedback inhibition 
mechanisms. These mechanisms are extremely important, since persistent activation 
of NF-κB can result in cellular damage, death or induce cancer due to acute 
inflammation and uncontrolled cell turnover. Among the physiological NF-κB 
termination mechanisms, the most rapid and essential is mediated by PDZ-LIM 
domain-containing protein 2 (PDLIM2). PDLIM2 is an ubiquitously expressed 
cytoplasmic-nuclear shuttling protein that terminates NF-κB activation by shuttling 
RelA to the nuclear matrix, where PDLIM2 enhances RelA proteasome-mediated 
degradation through its E3 ubiquitin ligase activity (Fu et al., 2010; Tanaka et al., 
2007). Tax directly shuts off this feedback inhibition mechanism by binding to 
PDLIM2, resulting in reduced RelA degradation, although this process results in the 
proteasomal degradation of Tax itself (Yan et al., 2009).  
Tax–mediated activation of the NF-κB pathway results in increased survival through 
the transcriptional activation of the anti-apoptotic factors Bcl-XL, Bfl1 and HIAP-1 
(Kawakami et al., 1999, Tsukahara et al., 1999; Nicot et al., 2000; De La Fuente et 
al., 2003) and the downregulation of the pro-apoptotic protein Bax (Brauweiler et al., 
1997). In addition, Tax induces a physical interaction between RelA and p53 that 
inhibits p53 transcriptional activity (Jeong et al., 2004). Furthermore, Tax represses 
p53 at the protein level via NF-κB using two different mechanisms: (i) activated IKK 
directly phosphorylates p53 to trigger p53 ubiquitination and proteasomal 
degradation by the β-TrCP ubiquitin ligase (Xia et al., 2009); (ii) activated NF-κB 
induces expression of MDM2, a ubiquitin ligase for p53 ubiquitination and 
degradation (Busuttil et al., 2010). 
 
1.4.1.3 Effects of Tax on the SRF/AP-1 pathway 
Tax increases the expression of the transcription factor AP-1 (activator protein -1) a 
homo- or heterodimeric complex of Fos (c-Fos, FosB, Fra1 and Fra2) and Jun (c-Jun, 
JunB and JunD) (Fujii et al., 1991; Fujii et al., 2000). Fos and Jun transcription is 
positively regulated by the serum responsive factor (SRF) in response to various 
stimuli such as cytokines, growth factors, stress signals and oncogenes. SRF binds to 
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the Fos/Jun promoters through two SRF responsive elements (SRE): a CArG box 
(CC(A/T)6GG) and an upstream Ets box (GGA(A/T)). Once SRF occupies the CArG 
box, the ternary complex factor (TCF) establishes protein interactions with SRF and 
subsequently binds the upstream Ets site. This complex then recruits the co-activators 
P/CAF and CBP/p300 to activate transcription. 
Tax activates the transcription of promoters under the control of SRE motifs  through 
the interaction with transcription factors associated with the SRF pathway (Alexandre 
and Verrier, 1991; Fujii et al., 1991; Alexandre et al., 1991). This interaction results 
in increased binding of SRF to the SRE (Dittmer et al., 1997). Once the complexes 
are stabilized, Tax recruits the coactivators CBP/p300 and P/CAF and mediates 
transactivation (Shuh and Derse, 2000).  
 
1.4.1.4 Non-transcriptional effects of Tax 
Tax also controls the cell cycle by interacting with cyclins-D1, -D2 and -D3 as well 
as with cyclin-dependent kinases (CDKs) 4 and 6 (Neuveut et al., 1998; Haller et al., 
2000; Haller et al., 2002; Fraedrich et al., 2005). Through these interactions, Tax 
stabilizes the cyclin D2/CDK4 complex and enhances its kinase activity, leading to 
hyperphosphorylation of the retinoblastoma protein (Rb). Tax also associates with the 
CDK inhibitors (CDKI) p15INK4b and p16INK4a and counteracts their CDK4-
inhibitory activity (Suzuki et al., 1996; Suzuki and Yoshida, 1997; Low et al., 1997; 
Suzuki et al., 1999). In addition, Tax binds to Rb and enhances its proteosomal 
degradation (Kehn et al., 2005). 
Tax also interacts with Tax1 binding protein (TAX1BP2) and Ran/Ran binding 
protein 1 (RanBP1), which control centrosome amplification during mitosis (Ching et 
al., 2006; Peloponese et al., 2005). Through these interactions, Tax induces 
supernumerary centrosomes and causes multipolar mitosis, thus contributing to 
aneuploidy, a hallmark of HTLV-1-infected cells (Marriott et al., 2002; Boxus and 
Willems 2009). Furthermore, Tax binds to and impairs the activity of Mad1, a 
constituent of the spindle assembly checkpoint (SAC) machinery (Jin et al., 1998). 
Tax interacts with the anaphase promoting complex (APC), which controls the 
metaphase-anaphase transition (Liu et al., 2005). APC directs the ubiquitination and 
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proteosomal degradation of cyclin B1 and Pds1p/securin. Securin and cyclin B1 
inhibit separase, a protease that destroys the connection links of sister chromatids. In 
normal cells, chromosomes start to segregate only after the kinetochore is subjected 
to the mechanical tension generated by the mitotic spindle (Nasmyth, 2005). Tax 
activates APC in the S phase, before the cell enters mitosis, decreasing the levels of 
cyclin B1 and securin, and resulting in the premature activation of separase, thus 
leading to unequal chromosomal separation between cells (Liu et al., 2005).  
Tax also promotes genome instability by targeting multiple components of the DNA 
damage repair pathway. Tax directly causes DNA damage generating double strand 
breaks both by modulating the timing of activation of the replication origins (Boxus 
et al., 2012) and by inducing oxidative stress (Kinjo et al., 2010). In addition, Tax 
attenuates the DNA damage response through sequestration and/or inhibition of 
critical proteins such as ATM, DNA-PK, CHK1-2 and p53 (Boxus and Willems, 
2012). 
Although Tax is a major target of CTLs, ATLL cells frequently lose the expression of 
Tax (see Paragraph 1.4.7) Thus, it is speculated that Tax plays an important role in 
the persistent proliferation of HTLV-1-infected cells mainly during the healthy carrier 
state. In this phase, the mutator phenotype conferred by Tax promotes accumulation 
of genetic and epigenetic changes that finally lead to Tax-independent proliferation 
and, following the silencing of Tax, escape from the host immune system (Yasunaga 
and Matsuoka, 2007). 
 
1.4.2 Rex 
Rex is a 189-amino acid, 27-kDa phosphoprotein coded by the x-III ORF of the pX 
region. Rex controls viral gene expression at the post-transcriptional level. The 
protein accumulates in the nuclei and nucleoli, and is able to shuttle between the 
nucleus and the cytoplasm (Palmeri and Malim, 1996; Narayan et al., 2003). This 
function of Rex is mediated through direct interaction with a 254-nucleotide stem-
loop cis-acting RNA element termed the Rex-responsive element (RxRE), present in 
the U3/R region of the 3' LTR of all plus-strand HTLV-1 transcripts (Grone et al., 
1994). 
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Different functional domains have been mapped in the Rex protein. The N-terminal 
arginin-rich region serves as nuclear localization signal (NLS) (Siomi et al., 1998; 
Nosaka et al., 1989) and as RNA binding domain (RBD) which mediates Rex binding 
to the RxRE (Grassmann et al., 1991; Bogerd et al., 1992). A leucine-rich sequence 
near the middle of the protein functions as activation domain (AD) (Weichselbraun et 
al, 1992b) and contains the nuclear export signal (NES) (Palmeri and Malim, 1996; 
Kim et al., 1996). The NES interacts with the protein chromosome region 
maintenance interacting protein 1 (CRM1/exporting 1) and allows export of the Rex-
RNA complexes from the nucleus to the cytoplasm (Bogerd et al., 1995). CRM1 
belongs to the importin-β family, whose members act as RNA transporters between 
nuclear and cytoplasmic compartments (Borgerd et al., 1998). Two regions adjacent 
to the NES are required for the assembly of Rex into multimeric structures upon 
binding to the RxRE (Bogerd et al., 1995; Bogerd and Greene, 1993). The formation 
of Rex multimers on the RxRE is critical for the nuclear export of viral mRNA, and 
mutations of the multimerization domain confer a dominant-negative phenotype to 
the protein (Bogerd et Greene, 1993). In addition to functioning as a Rex exporter, 
CRM1 serves as an inducing factor for Rex multimerization on viral mRNA by 
aiding in complex formation (Englmeier et al., 2001; Hakata et al., 1998). 
Collectively, the requirement for multiple bound copies of Rex on the RxRE is 
believed to protect the mRNA from being spliced, sequestered, or degraded in the 
nucleus. 
After Rex-RxRE binding and Rex multimerization, CRM1 is recruited into the Rex-
mRNA complex. The Rex-mRNA-CRM1 complex binds to RanGTP and translocates 
across the nuclear pore by interacting with phenylalanine-glycine rich nucleoporins. 
In the cytoplasm, RanGTP is then converted to RanGDP and is released from the 
Rex-mRNA complex. The conversion of GTP to GDP is catalyzed by the regulator of 
chromosome condensation 1 (RCC1) (Bischoff et al., 1991). 
Rex’s interaction with the RxRE is modulated by several cellular proteins. 
Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) competes with and inhibits 
Rex-RxRE interaction (Dodon et al., 2002). On the contrary, both Ran Binding 
Protein 3 (RanBP3) and SRC-associated in mitosis 68 (Sam 68) favour Rex function. 
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RanBP3 stabilizes the RanGTP-CRM1-Rex-mRNA complex in the nucleus (Hakata 
et al., 2003; Englmeier et al., 2001), and Sam 68 enhances the RNA-binding activity 
of Rex in a CRM1-independent manner (Reddy et al., 1999; Reddy et al., 2000). 
Experiments performed with protein kinase inhibitors indicated that Rex function is 
modulated by phosphorylation on serine/threonine residues (Adachi et al., 1990; 
Kesic et al., 2006), a property that highlights the importance of cellular factors in the 
multi-level regulation of HTLV-1 gene expression (Younis and Green, 2001). In 
addition to its role in RNA trafficking, Rex inhibits splicing in vitro during the initial 
phase of spliceosome formation (Bakker et al., 1996) and increases mRNA stability 
in the nucleus (Grone et al., 1996). 
Furthermore, Rex affects the expression of cellular genes. Rex is able to augment 
Tax-mediated upregulation of IL-2 and stabilize the IL-2 receptor-α chain (IL-2Rα) 
mRNA, thereby prolonging its half-life independently of nuclear-cytoplasmic 
transport (McGuire et al., 1993; Kanamori et al., 1990). Rex has also been shown to 
increase FynB (p59fyn) expression, possibly by affecting its splicing (Weil et al., 
1999). FynB is a src family protein-tyrosine kinase that regulates T-cell receptor 
stimulation (Cooke et al., 1991). Co-transfection experiments in Jurkat T-cells 
demonstrated that Rex augments Tax's ability to increase expression of vascular cell 
adhesion molecule-1 (VCAM-1) and lymphocyte function-associated antigen-3 
(LFA-3) (Valentin et al., 2001). Both VCAM-1 and LFA-3 are important proteins in 
T-cell adhesion that favour proliferation of uninfected cells and virus spread. 
Although Rex is not required for cellular immortalization in vitro, it is necessary for 
infectivity and viral persistence in vivo (Ye et al., 2003), since expression of the US 
and SS viral RNAs encoding structural proteins is necessary for the assembly of 
virions. The fact that these mRNAs depend on Rex for expression suggests that the 
Rex-RxRE interaction may function as a molecular switch controlling the transition 
between productive and latent phases of HTLV-1 infection. This hypothesis was 
recently tested in a study that analysed the temporal sequence of HTLV-1 gene 
expression in primary cells from infected patients using splice site-specific 
quantitative RT-PCR. This study revealed a two-phase kinetics of HTLV-1 
expression, with the tax/rex mRNA preceding expression of other viral transcripts. 
24 
 
Studies carried out with Rex knock-out molecular clones of HTLV-1 demonstrated 
the strict Rex-dependency of the two-phase kinetics (Rende et al., 2011).  
 
1.4.3 p21rex 
p21rex is a truncated isoform of Rex lacking the N-terminal arginine-rich domain. It 
was hypothesized that it might act as a repressor of full-length Rex, inhibiting the 
expression of transcripts coding for structural proteins, enzymes and accessory 
proteins (Heger et al., 1999). However, this function of p21rex as a latency-inducing 
factor in HTLV-1 life cycle has been questioned by other authors (Bai et al., 2012). 
 
1.4.4 p30/tof 
p30/tof is a 241-amino acid protein coded by the x-II ORF of the pX region. p30/tof 
is a nucleolar-nuclear non-shuttling protein (Ciminale et al., 1992; D’Agostino et al., 
1997) whose sequence contains three NLS and an arginine-rich nucleolar retention 
signal (NoRS) (D'Agostino et al., 1997; Ghorbel et al., 2006). An HTLV-1 molecular 
clone containing a mutation in the x-II ORF is still able to produce infective virions 
and immortalize human T-lymphocytes (Robek et al., 1998), but shows a drastic 
reduction in in vivo infectivity in animal models (Bartoe et al., 2000; Valeri et al., 
2010).  
p30/tof functions at the post-transcriptional level by inhibiting the nuclear export of 
the tax/rex mRNA; this results in a global inhibition of viral gene expression, 
suggesting that p30/tof might act as a latency factor (Nicot et al., 2004).  
Additional studies shed light on the mechanism used by the virus to discriminate 
between viral mRNAs that are p30/tof responsive (tax/rex) and those that are Rex 
responsive (gag/pro/pol and env). p30/tof interacts with the RNA-binding domain of 
Rex and with the tax/rex mRNA, building a p30/tof-Rex-tax/rex mRNA ternary 
complex that prevents Rex-RxRE binding to the tax/rex mRNA; p30/tof efficiently 
interacts with Rex only when it is bound to RNA (Sinha-Datta et al., 2007). Two 
domains are crucial to the formation of the ternary complex: the Rex binding domain 
(RexBD) on the p30/tof protein and the p30 mRNA responsive element (p30RE) on 
the tax/rex mRNA. The ability of p30/tof to interact with tax/rex but not with 
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gag/pro/pol or env mRNAs explains why p30/tof is able to prevent tax/rex nuclear 
export but has little or no effect on other viral mRNAs (Sinha-Datta et al., 2007).  
Although it is critical for HTLV-I to reduce its expression to evade immune detection 
and clearance, complete latency would not benefit the virus, which needs Tax 
expression to promote clonal expansion of infected cells. In agreement with this 
model, it was demonstrated that Rex permits export of residual p30/tof-bound tax/rex 
mRNA allowing a low level of virus expression (Sinha-Datta et al., 2007). Rex may 
oppose p30/tof function by recruiting a limiting cellular factor and inducing a 
conformational change in p30/tof or in the local RNA structure, thus releasing p30/tof 
from its p30 responsive element (p30RE) and allowing export of some tax/rex mRNA 
to the cytoplasm. 
In addition to its post-transcriptional functions, p30/tof modulates transcription from 
CREB-responsive promoters with cellular CRE and viral TRE sequences, by 
interacting with the co-activator CBP/p300 (Zhang et al., 2000; Zhang et al., 2001). 
p30/tof interacts with the kinase-inducible exchange domain (KIX) of p300/CBP, 
also known to bind to CREB and Tax. p30/tof modulation of the transcription from 
the CRE sequences depends on its expression levels and on the presence of Tax. At 
low levels of expression and in the absence of Tax, p30/tof activates the transcription 
from the HTLV-I LTR. On the other hand, at high levels, p30/tof represses Tax-
mediated LTR transcription. Furthermore, p30/tof can disrupt the assembly of the 
CREB–Tax–p300/CBP complex on TRE sequence. Taken together, these data 
suggest that p30/tof might decrease transcription of the viral genome, thereby 
facilitating viral latency. 
p30/tof also influences the expression of a number of cellular genes at the 
transcriptional and post-transcriptional level, including adhesion molecules and genes 
involved in T-cell activation and apotosis (Michael et al., 2004; Taylor et al., 2009). 
Finally, p30/tof recruits the co-activator Tat-interacting protein 60 (TIP60) and 
promotes the formation of the Myc/TIP60 transcription complex on the Myc-response 
E-box element, thus transactivating transcription (Awasthi et al., 2005). Due to the 
importance of Myc as a proto-oncogene, p30/tof may contribute to the transformation 
of the HTLV-1-infected cell. In fact, p30/tof modulates expression of cellular genes 
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involved in the cell cycle and apoptosis (Michael et al., 2004; Taylor et al., 2009; 
Datta et al., 2007). p30/tof-mediated alteration of cell cycle events was promposed to 
promote early viral spread and T-cell survival (Datta et al., 2007). 
 
1.4.5 p13 
p13 is a 87-amino acid protein coded by the x-II ORF of the pX region. p13 
corresponds to the C-terminal portion of p30/tof (Koralnik et al., 1992) and 
accumulates prevalently in mitochondria (Ciminale et al., 1999). 
Studies of a p13-knockout virus showed that although the protein is dispensable for 
viral replication in cultured cells (Derse et al., 1997; Robek et al., 1998), it is required 
for establishing a persistent infection in a rabbit experimental model (Hiraragi et al., 
2006). 
Functional mapping of p13 revealed a mitochondrial targeting signal (MTS) spanning 
amino acids 21-30 (Ciminale et al., 1999). Upon exposure to membrane-mimetic 
solutions, the MTS (LRVWRLCTRR) folds in an amphipathic α-helix, with a 
positively charged face of four arginine residues (Figure 4A, left) (D'Agostino et al., 
2002). Unlike canonic MTS, the MTS of p13 is not cleaved upon import and 
substitution of the four arginines with glutamines, prolines, or alanines and leucines 
does not affect mitochondrial targeting (Ciminale et al., 1999) (Figure 4A, right). 
Immunoelectron microscopy and fractionation experiments demonstrated that p13 is 
an integral membrane protein and accumulates mainly in the inner mitochondrial 
membrane. p13 induces specific alterations in mitochondrial morphology, resulting in 
isolated clusters of round-shaped, swollen mitochondria (Ciminale et al., 1999; 
D'Agostino et al., 2002; D'Agostino et al., 2005). Site-directed mutagenesis 
experiments demonstrated that the arginines of the amphipathic α-helical domain are 
essential to induce mitochondrial fragmentation/swelling (D'Agostino et al., 2002). 
The subcellular localization of p13 could be influenced by its expression level and the 
physiological state of the cell; in fact, although the protein has been localized mainly 
in the mitochondria, occasionally it may be detected also in the nucleus (Koralnik et 
al., 1993; D’Agostino et al., 1997). Interestingly, a recent study has demonstrated 
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that, upon co-expression with Tax, p13 is partially routed to nuclear speckles 
(Andresen et al., 2011). 
In vitro assays carried out using isolated mitochondria and purified full-length 
synthetic p13 demonstrated that it triggers an influx of K+ in mitochondria, leading to 
membrane depolarization, increased activity of the electron transport chain (ETC) and 
mitochondrial reactive oxygen species (ROS) production (Silic-Benussi et al., 2009). 
The increased ROS production, along with membrane depolarization, lowers the 
opening threshold of the permeability transition pore (PTP), a mitochondrial channel 
controlling apoptosis (Figure 4B) (Rasola and Bernardi, 2007). p13 mutants in the 
amphipathic α-helix have little or no effects on ROS production. The effects of p13 
on inner membrane potential (∆ψ) and ROS production were also observed in living 
cells (Biasiotto et al., 2010; Silic-Benussi et al., 2010b).  
Studies of the influence of p13 on ROS indicate that the protein may have a distinct 
impact on cell survival and proliferation, depending on the cell’s inherent ROS levels, 
with death-promoting effects in transformed cells and activation predominating in 
normal resting T-cells (Silic-Benussi et al., 2010a). p13 sensitizes transformed cells 
to proapototic stimuli such as Fas ligand (FasL) and ceramide (Hiraragi et al., 2005; 
Silic-Benussi et al., 2004) or glucose deprivation (Silic-Benussi et al., 2010b). 
Interestingly, the effect of p13 on FasL-mediated apoptosis is enhanced by Ras 
overexpression and blocked by inhibitors of Ras (Hiraragi et al., 2005; Silic-Benussi 
et al., 2004). Furthermore, p13 interacts with farnesyl pyrophosphate synthase, a key 
enzyme in the synthesis of substrates required for the prenylation of Ras (Lefèbvre et 
al., 2002a; Lefèbvre et al., 2002b), suggesting that p13 may affect the Ras signal 
transduction pathway. These results suggest that, in the context of transformed cells, 
p13 might act as a viral tumor suppressor reducing proliferation and favoring cell 
death especially in conditions of reduced substrate availability.  
In contrast, expression of p13 in primary quiescent T-cells results in ROS-dependent 
activation (Silic-Benussi et al., 2010b). The dual effect of p13 in normal versus 
transformed cells is consistent with a current model that compares the effects of ROS 
on cell turnover to a rheostat (Rustin, 2002). According to this model, an increasing 
gradient of ROS is found from resting to activated- to transformed- to apoptotic cells. 
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This model is also relevant in the context of T-cell activation, as engagement of the 
TCR induces rapid generation of ROS, in part produced by mitochondria. ROS act as 
powerful second messengers controlling redox-sensitive pathways such as the NF-κB, 
MEK, ERK and LCK, and modulate the opening threshold of the permeability 
transition pore (PTP) (Williams and Kwon, 2004). 
Another mechanism through which p13 might control T-cell activation and death is 
by influencing calcium (Ca2+) homeostasis at the mitochondrial level. Ca2+ uptake in 
the mitochondrial matrix controls the activity of key metabolic enzymes, stimulating 
ATP production and aerobic metabolism. Excessive calcium accumulation in 
mitochondria triggers PTP opening and apoptosis (Giacomello et al., 2007). The 
analysis of Ca2+ concentration in different intracellular compartments (endoplasmic 
reticulum, mitochondria and cytosol) following histamine stimulation revealed that 
p13 specifically reduces mitochondrial Ca2+ uptake (Biasiotto et al., 2010). 
Taken together, these findings suggest that in the context of the HTLV-1 propagation 
strategy, p13 could provide a mechanism to increase the pool of normal infected T-
lymphocytes while promoting the elimination of cells occasionally acquiring a 
transformed phenotype, thus favouring life-long persistence of the virus in the host in 
the absence of disease. 
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Figure 4. Schematic model of p13 structure and mitochondrial functions. A: The amphipathic α-
helix of p13. Rs indicate the four positively charged arginine residues in positions 22, 25, 29 and 30 of 
p13 (left). The substitution of these arginines with glutamines, prolines, or alanines and leucines is 
indicated as blue dots in the p13 mutant (right). These substitutions do not affect mitochondrial 
targeting, but are essential for function. B: In the inner mitochondrial membrane p13 triggers an 
inward K+ current that leds to depolarization and increased respiratory chain activity (ETC), reactive 
oxygen species (ROS) production and lowering of the opening threshold of the permeability transition 
pore (PTP). wt, wild type; mut, mutant; K+, potassium, ∆Ψ mitochondrial membrane potential; ETC, 
electron transport chain, H+, protons, O2, molecular oxygen, O2-, superoxide anion, H2O2 hydrogen 
peroxide, PTP, permeability transition pore. (Adapted from Silic-Benussi et al., 2010a). 
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1.4.6 p12 
p12 is a 99-amino acid hydrophobic protein coded by the x-I ORF. p12 localizes in 
the endoplasmic reticulum (ER) and in the Golgi apparatus (Koralnik et al., 1993; 
Ding et al., 2001; Johnson et al., 2001). The protein is dispensable for HTLV-1 
replication in vitro, but plays a key role in establishing a productive viral infection in 
vivo (Collins et al., 1996; Derse et al., 1997; Robek et al., 1998 Albrecht et al., 2000; 
Valeri et al., 2010). 
p12 contains four proline-rich Src homology 3 (SH3) domains, two trans-membrane 
domains, two leucine zipper motifs and a calcineurin-binding motif. The SH3 
domains are responsible for binding cellular signaling proteins (Koralnik et al., 1993). 
Together the trans-membrane domains and the leucine zipper motifs mediate 
targeting of the protein to the ER and other endomembrane compartments and 
dimerization (Ding et al., 2001; Johnson et al., 2001). The calcineurin-binding motif 
allows p12 to bind calcineurin, a Ca2+-responsive protein phosphatase that controls 
the nuclear factor of activated T-cells (NFAT) activity, thus influencing gene 
expression of infected T-lymphocytes (Kim et al., 2003; Albrecht et al., 2002). In 
addition, p12 interacts with calreticulin and calnexin, two ER-resident proteins that 
regulate Ca2+ storage and signalling, and enhances Ca2+ release from the ER stores, 
resulting in increased cytosolic Ca2+ levels (Ding et al., 2001; Ding et al., 2002). This 
contributes to p12-mediated NFAT activation and ultimately decreases the threshold 
for T-cell activation (Nicot et al., 2005). 
In the context of the whole virus, it is possible that p12 might act in concert with p13 
to control intracellular Ca2+ homestasis (Biasiotto et al., 2010). Combined expression 
of p12 and p13 might in fact enhance the amplitude and duration of cytosolic Ca2+ 
transients in response to TCR stimulation, resulting in enhanced NFAT activation. 
p12 also binds the β and γc chains of the interleukin-2 receptor (IL-2R), thus reducing 
dependency on IL-2 for T-cell activation (Mulloy et al., 1996; Nicot et al., 2001). The 
IL-2R β chain in fact is involved in the activation of the Janus-associated kinases 1 
and 3 (Jak1 and Jak3), which phosphorylate and activate the signal transducers and 
activators of transcription-5 (STAT-5). By binding to the cytoplasmic domain of IL-
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2R β, p12 determines an increase in STAT-5 activity in the absence of IL-2, thus 
providing a proliferative advantage to T-cells (Nicot et al., 2001). 
p12 was also shown to sequester free major histocompatibility complex class I heavy 
chains (MHC-I-Hc), preventing their binding to β2-microglobulin. p12-bound MHC-I 
molecules are translocated in the cytosol and degraded by the proteasome. The 
overall result of this interaction is a decrease in functional MHC-I on the surface of 
HTLV-1-infected cells, which would favour their escape from CTL recognition and 
clearance by the immune system (Johnson et al., 2001). Furthermore, p12 causes a 
reduction in the expression of intracellular adhesion molecule 1 and 2 (ICAM-1 and 
ICAM-2), which mediate adhesion of natural killer (NK) cells to the infected cells, 
resulting in the protection of HTLV-1-infected CD4+ T-cells from NK-mediated 
cytotoxicity (Banerjee et al., 2007).  
p12 is proteolytically cleaved to generate p8, a protein that enhances T-cell contact by 
interacting with lymphocyte function-associated antigen-1 (LFA-1) and ICAM-1 and 
mediates formation of intracellular conduits among T-cells, thereby increasing viral 
transmission (Van Prooyen et al., 2010) (see also Paragraph 1.2). 
 
1.4.7 Hbz 
The minus strand of the HTLV-1 genome contains one ORF located in the pX region. 
Transcription from antisense promoters generates at least two different transcripts, 
one spliced (hbz sp1) and the other unspliced (hbz us) (Figure 2B). (Cavanagh et al., 
2006; Murata et al., 2006; Satou et al., 2006). HBZ is not necessary for viral 
replication or immortalization in vitro, but increases infectivity and viral persistence 
in vivo (Arnold et al., 2006). 
Hbz sp1 is translated into a protein of 206 amino acids, while hbz us produces a 
protein of 209 amino acids. The two HBZ isoforms differ by seven amino acids in the 
N-terminus (Murata et al., 2006). The HBZ SP1 protein is more abundant and has a 
longer half-life than the HBZ US isoform (Yoshida et al., 2008). The HBZ protein 
contains an N-terminal transcriptional activation domain (AD), a central domain (CD) 
and a C-terminal basic ZIP domain (bZIP) (Gaudray et al., 2002). HBZ accumulates 
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in nuclear speckles through its NLS which contains two regions rich in basic amino 
acids and a DNA binding domain (Hivin et al., 2005). 
The transcription of hbz sp1 is dependent on Sp1 (Yoshida et al., 2008), a basal 
transcription factor critical for many TATA-less promoters (Boam et al., 1995; Liu 
and Cowell, 2000). The TRE sequence in the 3' LTR enhances transcription of the 
hbz anti-sense transcripts (Yoshida et al., 2008; Landry et al., 2009). However, this 
enhancing activity is relatively weak compared to that mediated by the TREs present 
in the 5’ LTR promoter. This is consistent with the finding that transcription of the 
hbz gene is relatively constant in ATLL cases regardless of the expression levels of 
Tax (Saito et al., 2009). 
HBZ interacts with a number of transcription factors, including CREB-2, p300/CBP, 
Jun family members, and NF-κB (Matsuoka and Green, 2009). 
HBZ binds CREB-2 and CBP/p300, respectively, through its bZIP domain 
(Lemasson et al., 2007; Hagiya et al., 2011) and via LXXLL-like motifs in its N-
terminal region (Clerc et al., 2008). The interaction of HBZ with CREB-2 and 
CBP/p300 inhibits Tax-induced viral transcription from the 5' LTR by dissociating 
CREB-2 from TREs and counteracting the binding between CBP/p300 and Tax 
(Gaudray et al., 2002). Similarly, HBZ alters the effect of CREB proteins upon 
cellular gene transcription. 
Through its bZIP domain, HBZ forms heterodimers with several AP-1 transcription 
factors, such as c-Jun, JunB and JunD, and modulates their activity (Basbous et al., 
2003; Thebault et al., 2004). Binding of HBZ to JunB and c-Jun decreases their DNA 
binding activity by preventing their interaction with Fos (Matsumoto et al., 2005). 
Furthermore, HBZ reduces c-Jun stability by targeting it for proteasomal degradation 
(Matsumoto et al., 2005), and sequestres JunB within nuclear bodies (Hivin et al., 
2007). In contrast, the interaction of HBZ with Jun-D stimulates its transcriptional 
activity (Thebault et al., 2004), and results in the activation of JunD-dependent 
cellular genes including human telomerase reverse transcriptase (hTERT) (Kuhlmann 
et al., 2007). 
HBZ suppresses the activation of the canonical NF-κB pathway through inactivation 
of the NF-κB transcription factor p65. Inhibition of p65 by HBZ is mediated by two 
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different mechanisms: it inhibits the DNA binding of p65 and induces p65 
ubiquitination and degradation by increasing the expression of PDLIM2, the E3 
ubiquitin ligase of p65 (Zhao et al., 2009). Interestingly, HBZ does not inhibit the 
non-canonical NF-κB pathway. 
HBZ expression is associated with proliferation of ATLL cells in vitro and in vivo 
(Satou et al., 2006; Arnold et al., 2008). Mutational analyses of the hbz gene showed 
that hbz mRNA, rather than HBZ protein, has a growth-promoting effect on T-cells, 
possibly by upregulating the transcription of the E2F1 gene and its downstream 
targets (Satou et al., 2006). This function of HBZ as a non-coding transcript is 
consistent with the fact that most of the HBZ mRNAs are detected in the nuclear 
compartment (Rende et al., 2011). 
An intriguing aspect of ATLL pathogenesis is the fact that Tax expression is not 
detected in about 60% of leukemia cases. Three mechanisms for inactivating Tax 
expression in ATLL cells have been described: 1) genetic changes (nonsense 
mutation, deletion, and insertion) of the tax gene (Takeda et al., 2004; Furukawa et 
al., 2001), 2) deletion of the 5' LTR (Tamiya et al., 1996; Miyazaki et al., 2007) and 
3) DNA methylation of the 5' LTR (Koiwa et al., 2002; Taniguchi et al., 2005). Since 
Tax is the major target of CTLs in vivo (Kannagi et al., 1991), one hypothesis is that 
these mechanisms disrupting Tax expression facilitate the escape of ATLL cells from 
host CTL. Interestingly, analyses of HTLV-1 proviruses in ATLL cells revealed an 
intact hbz gene and lack of deletion or methylation of the 3' LTR, suggesting that hbz 
expression may be essential for the maintenance of the ATLL phenotype (Fan et al., 
2010; Yoshida et al., 2008). A recent study described a significant association 
between the detection of HBZ-specific CD8+ T-cell responses with low viral load 
and asymptomatic carriage of HTLV-1. This result is consistent with the finding that 
the HLA class 1–restricted T-cell response plays an important part in limiting HTLV-
1 viral load and the risk of HAM (Macnamara et al., 2010). 
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1.5. Role of the NF-κB pathway in HTLV-1 pathogenesis 
1.5.1 NF-κB activation in ATLL 
NF-κB is involved in all stages of the natural history of ATLL, from initiation to 
invasion and metastasis (Xiao and Fu, 2011). Tax is the major driver of NF-κB 
persistent activation during HTLV-1 infection (Paragraph 1.4.1.2), although Tax-
independent mechanisms are also important, especially in acute ATLL (Paragraph 
1.5.2). 
During the early stages of ATLL, NF-κB induces expression of genes involved in T-
cell proliferation and survival such as IL-2Rα (Ballard et al., 1988), IL-6, CD30, 
CD40, OX40/OX4OL (Pankow et al., 2000; Ohtani et al., 1998), TNF-α, 4-1BB 
(Pichler et al., 2008), Bcl-xL, (Tsukahara et al., 1999); and cIAP (Wäldele et al., 
2006). Furthermore, NF-kB is important in Tax-induced IL-2-dependent and -
independent cell growth as well as in HTLV-1-induced T-cell immortalization 
(Iwanaga et al., 1999; Robek and Ratner, 1999). 
Persistent NF-κB activation in ATLL also results in the bypass of cell cycle 
checkpoints and p53-mediated apoptosis through Tax-mediated effects (Paragraph 
1.4.1.2) and through the mutual repression of NF-κB and p53, resulting from the 
competition for CBP/p300 proteins (Webster and Perkins, 1999).  
NF-κB may also contribute to ATLL progression by causing DNA damage and 
oncogenic mutations through the induction of inflammation-mediated production of 
ROS and reactive nitrogen species. The pro-inflammatory effects of NF-κB are also 
likely to play a role in the development of HAM/TSP (Banerjee et al., 2010). 
Interestingly, NF-κB also activates many other pro-oncogenic molecules, such as c-
Myc and phosphatidylinositol-3-kinase (PI3K) to induce expression of human 
telomerase reverse transcriptase (hTERT) (Sinha-Datta et al., 2004), and promotes the 
expression of genes involved in tumor progression and metastasis such as matrix 
metalloproteinase-9 (MMP-9) (Mori et al., 2002) and Fascin (Kress et al., 2011). 
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1.5.2 Tax-independent mechanisms of NF-κB activation 
Although Tax expression is lost in about 60% of ATLL cases, both the canonical and 
non-canonical NF-κB pathways are still strongly activated in Tax-negative ATLL 
cells, suggesting Tax-independent mechanisms of NF-κB activation (Hironaka et al., 
2004). A recent study revealed the downregulation of miR-31 as an example of these 
mechanisms (Yamagishi et al., 2012). miR-31 specifically binds to the 3’ UTR of the 
mRNA of the NIK kinase, and represses its expression, leading to the inhibition of 
the non-canonical NF-κB pathway. In ATLL patients, miR-31 is profoundly 
repressed through the action of the Polycomb family of repressors, resulting in 
constitutive activation of the NF-κB pathway.  
Other mechanisms of Tax-independent NF-κB activation may be attributed to stress 
conditions and epigenetic or genetic alterations caused by HTLV-1 infection. For 
example, DNA damage can lead to strong NF-κB activation (Miyamoto, 2011). 
Furthermore, other viral proteins may play an indirect role by influencing cellular 
pathways that modulate NF-κB activity (e.g. ROS homeostasis, Paragraph 1.6).  
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1.6 Crosstalk between NF-κB signalling and ROS homeostasis 
The NF-κB pathway and ROS homeostasis are connected by a complex reciprocal 
crosstalk. On one hand, the expression of both pro-oxidant and antioxidant proteins is 
transcriptionally controlled by NF-κB (Table 1); thus NF-κB can influence 
intracellular ROS levels (Morgan and Liu, 2011).  
 
 
 
Table 1. NF-кB target genes involved in redox homeostasis. (Adapted from Morgan and Liu, 2011).  
 
On the other hand, NF-κB was the first transcription factor shown to be regulated by 
ROS (Schreck et al., 1991). ROS can modulate the NF-κB pathway both positively 
and negatively, depending on the cellular context and on the nature of the oxidative 
stress. 
In the nucleus, ROS-mediated oxidation of p50 on cysteine 62 results in reduced 
DNA binding capacity (Toledano et al., 1993; Matthews et al., 1993). A similar effect 
may result from S-nitrosylation of cysteine 62 by nitric oxide (NO) produced by the 
inducible nitric oxide synthase (iNOS). Since iNOS is an NF-κB target gene (Table1), 
this mechanism acts as a negative feedback loop of the NF-κB pathway in the nucleus 
(Matthews et al., 1996). NF-κB oxidation can be counteracted by the ROS scavenger 
NF-кB target genes involved in redox homeostasis 
Pro-oxidants Antioxidants 
NADPH oxidase (NOX2) Manganese Superoxide Dismutase (MnSOD) 
Xanthine Oxidase/Dehydrogenase (XOR) Copper-Zinc Superoxide Dismutase (Cu,Zn-SOD) 
Inducible Nitric Oxide Synthase (iNOS) Ferritin Heavy Chain (FHC) 
Neuronal Nitric Oxide Synthase (nNOS) Catalase 
Cyclooxygenase-2 (COX-2) Thioredoxin-1 (Trx1) 
Arachidonate 12-lipoxygenase (LOX-12) Thioredoxin-2 (Trx2) 
Arachidonate 5-lipoxygenase (LOX-5) Glutathione S-transferase pi (GST-pi) 
Cytochrome p450 enzyme Metallothionein-3 (MT3) 
 NAD(P)H dehydrogenase [quinone] 1 (NQO1) 
 Heme Oxigenase-1 (HO-1) 
 Glutathione peroxidase-1 (Gpx1) 
 Dihydrodiol dehydrogenase (DDH1) 
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thioredoxin (TRX) and by the nuclear apurinic apyrimidinic endonuclease redox 
effector factor-1 (APE1-/Ref-1) (Matthews et al., 1992; Ando et al., 2008). 
Interestingly, in Jurkat T-cells hydrogen peroxide (H2O2) mediates the 
phosphorylation of IκBα on tyrosine 42 (rather than the canonic serine 32 and 36) by 
the Syk tyrosine kinase, resulting in calpain-mediated degradation of IκBα (Schreck 
et al., 1991; Takada et al., 2003; Schoonbroodt et al., 2000). This atypical mechanism 
of NF-κB activation has been observed in other cellular contexts after treatment with 
pervanadate (a potent tyrosine phosphatase inhibitor) and after 
hypoxia/reoxygenation (Imbert et al., 1996; Livolsi et al., 2001). In this case, c-Src 
phosphorylates IκBα on tyrosine 42 and the phosphorylated IκBα binds the SH2 
domains of the p85α regulatory subunit of PI3K, thus releasing NF-κB and allowing 
its nuclear translocation (Béraud et al., 1999; Fan et al., 2003; Lluis et al., 2007). 
In addition, the canonical IKK-mediated phosphorylation of IκBα on serine 32 and 36 
is enhanced by H2O2 in HeLa cells and in the CEM T-cell line. In HeLa cells, IKK 
activation is mediated by protein kinase D (PKD), which tyrosine-phosphorylates 
IKKβ (Storz et al, 2003). In CEM T-cells, IKK activation relies on the expression of 
the lipid phosphatase SH2-containing inositol phosphatase-1 (SHIP-1) (Krystal, 
2000). The mechanism through which SHIP-1 activates the IKK complex is still 
unknown. Other studies have shown that H2O2  inactivates IKK through oxidation of 
cysteine 179 of IKKβ (Reynaert et al., 2006). 
Other oxidants, such as hypochlorous acid (HOCl) (Barua, et al., 2001; Ogino et al., 
2005), singlet oxygen (O2˙-) (Volanti et al., 2002; Reelfs et al., 2004) and 
peroxinitrites (ONOO-, PN) (Cooke et al., 2002; Jozsef and Filep, 2003; Hattori et al., 
2004; Levrand et al., 2005) modulate NF-κB with different mechanisms and 
outcomes depending on the cell type. 
In addition to the direct effect of ROS on the NF-κB pathway, pro-inflammatory 
cytokines such as interleukine 1β (IL-1β) and tumor necrosis factor α (TNF-α) induce 
NF-κB activation in a ROS-dependent manner. The redox dependence of NF-κB 
activation by IL-1β is cell-type specific. In lymphoid cells, the main generator of 
ROS after exposure to IL-1β is 5-lypoxigenase (5-LOX) (Bonizzi et al, 2000). In 
monocytic cells, ROS are produced mainly by the NADPH oxidase (Nox) complex 
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(Bonizzi et al., 1999); in epithelial cells, the major source of ROS is Nox2, a 
phagocytic NADPH oxidase also expressed in non-phagocytic cells (Li et al., 2006).  
ROS play an important role in the TNF-induced cross-talk between JNK and NF-κB 
activation. These two pathways have opposite biological roles: JNK activation 
promotes apoptosis through the mitochondrial-dependent pathway (Karin et al., 
2005), whereas NF-κB activation promotes cell survival. NF-κB down-regulates JNK 
activation by suppressing TNF-induced ROS accumulation (Sakon et al., 2003; 
Ventura et al., 2004). 
These powerful crosstalk mechanisms suggests that viral proteins controlling ROS 
homeostasis may add a further layer of complexity in the deregulation of the NF-κB 
pathway in infected cells. Testing this hypothesis was a major aim of the present 
study.  
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2. AIM OF THE STUDY 
 
HTLV-1 is the causative agent of adult T-cell leukemia/lymphoma (ATLL), an 
aggressive malignancy of mature CD4+ T-cells. Tax-mediated NF-κB activation is a 
key determinant of HTLV-1 pathogenicity, especially in the initial phase of the 
neoplastic transformation process. Tax activates both the canonical and non-canonical 
NF-κB pathways, promoting NF-κB translocation to the nucleus and transcription of 
genes that favour T-cell proliferation and survival. Our previous studies showed that 
the p13 protein of HTLV-1 enhances mitochondrial ROS production, resulting in 
activation of primary T-cells. ROS constitute a homeostatic rheostat that controls the 
activity of several key pathways, including NF-κB. 
The work described in the present thesis was aimed at testing the hypothesis that Tax 
and p13 might act in concert to activate the NF-κB signal transduction pathway in 
primary T-cells. To this end, we optimized a transfection protocol for primary T-cells 
using an innovative approach based on the electroporation of in vitro-transcribed 
RNA. The activation of the NF-κB pathway was analysed by measuring the 
expression of the NF-κB target genes CD25 by flow cytometry and 4-1BB by 
quantitative RT-PCR.  
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3. MATERIALS AND METHODS 
 
3.1 Cell culture 
The Jurkat T-cell line was maintained in RPMI 1640 medium (Sigma-Aldrich) 
supplemented with 10% fetal calf serum (FCS) (Life Technologies), 2 mM L-
glutamine (GIBCO), 100 units/mL penicillin, and 20 units/mL streptomycin (Sigma-
Aldrich). Peripheral blood mononuclear cells (PBMCs) from healthy donors were 
isolated by Ficoll-Hypaque gradient centrifugation using a standard protocol. After 
transfection, Jurkat cells were cultured in RPMI 1640 supplemented with 10% FCS 
and 2 mM L-glutamine, whereas PBMCs were cultured in RPMI 1640 or IMDM 
(LONZA) supplemented with 10% FCS and 2 mM L-glutamine. 
 
3.2 Plasmids 
RNA to be transfected was in vitro-transcribed using a system based on vector pST1-
GFP (Figure 5) (Holtkamp et al., 2006). pST1-GFP contains the T7 phage promoter 
sequence at the 5’ end and a 120 base pair-long poly(A) tail at the 3’ of the coding 
sequence of interest. In addition, the pST1-vector contains two tandemly repeated 
human β-globin untranslated regions (UTRs) between the coding sequence and the 
poly(A) tail that increase the stability of the in vitro-transcribed RNA. This vector can 
be used to in vitro-transcribe genes of interest, ensuring high transcript stability and 
translational efficiency (Holtkamp et al., 2006). The vector can be linearized by 
restriction digestion with the Sap I enzyme, whose unique site is located downstream 
of the poly(A).  
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Figure 5. The pST1-GFP plasmid. The vector contains the T7 phage promoter sequence at the 5’ and 
a 120 base pair-long poly(A) tail (grey arrow) at the 3’ of the coding sequence of the green fluorescent 
protein (GFP, green arrow). Two tandemly repeated human β-globin UTRs (2βgloUTRs, red arrow), 
between the GFP coding sequence and the poly(A) tail, increase the stability of the in vitro-transcribed 
RNA. The Sap I unique site, located downstream of the poly(A) tail, can be used to linearize the vector 
(Adapted from Holtkamp et al., 2006). 
 
The coding sequence of Tax was amplified by end-point PCR from the pcTax 
plasmid (Rimsky et al., 1988) using the following 5’ tagged set of primers: Xba I-Tax 
forward, 5’-ATATCTAGACTGCCATGGCCCACTT-3’ and Tax-Xho I reverse, 5’-
GTCTCTCGAGTCAGACTTCTG-3’. The resultant Xba I-Tax-Xho I fragment was 
cloned in the intermediate vector pCR-Blunt (Life Technologies) and digested with 
Xba I and Xho I. The product of the digestion was then cloned in the final vector 
pST1-delta-GFP. The pST1-delta-GFP vector was generated from the pST1-GFP 
following deletion of the green fluorescent protein (GFP) coding sequence through an 
Xba I-Xho I restriction digestion. 
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The coding sequence of p13GFP was obtained from the pcDNAp13GFP plasmid 
(Silic-Benussi et al., 2010b) through an Hind III-Xho I restriction digestion. The 
p13GFP fragment was cloned in the intermediate pCR-Blunt vector and cut with 
Hind III and Xho I to generate the Hind III-p13GFP-Xho I fragment. This fragment 
was then ligated to the pST1-delta-GFP2 vector previously obtained from the pST1-
GFP digested with Hind III-Xho I. Attemps to express untagged p13 using this 
system were unsuccessful.  
The pST1-Tax and pST1-p13GFP plasmids, together with the control pST1-GFP 
plasmid, were linearized using the FastDigest Sap I (Lgu I) restriction enzyme 
(Fermentas, Thermo Scientific), purified from an agarose gel using the 
GENECLEAN Turbo kit (MP Biomedicals) and quantitated using tahe Nanodrop 
ND-1000 spectrophotometer (Thermo Scientific). 
 
3.3 In vitro transcription and capping 
The Sap I-linearized pST1-Tax, pST1-p13GFP, and pST1-GFP plasmids were 
subjected to in vitro-transcription and capped using the mMESSAGE mMACHINE 
T7 kit (Ambion, Life Technologies). The reaction was performed for 2 hours at 37°C 
following the manufacturer's recommendations (Table 2). Thereafter, 1 µl of TURBO 
DNase (Ambion, Life Technologies) was added, and samples were incubated for 15 
minutes at 37°C to remove DNA templates. The in vitro-transcribed RNAs were then 
purified using the RNeasy MinElute Cleanup kit (Qiagen) according to the 
manufacturer’s instruction, and used in transfections. 
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Component  Volume  
Nuclease-free Water to 20 µl 
2X NTP/CAP  10 µl 
10X Reaction Buffer  2 µl 
Linear template DNA  1 µg 
Enzyme Mix 2 µl 
 
 
Table 2: In vitro transcription and capping reactions. The 2X NTP/CAP is a buffered solution that 
contains 15 mM ATP, 15 mM CTP, 15 mM UTP, 3 mM GTP and 12 mM cap analog 
[m7G(5')ppp(5')G]; the 10X reaction buffer contains salts, buffer, dithiothreitol, and other components; 
the enzyme mix is a 50% glycerol buffered solution containing the T7 RNA polymerase, an RNase 
inhibitor and other components. 
 
3.4 Transfections 
The transfection experiments described in the present thesis were realized as part of a 
collaborative project with Dr. A. Kress at the Institute of Clinical and Molecular 
Virology, University of Erlangen-Nuremberg, Erlangen, Germany, in the context of 
the DAAD-Vigoni Program, German-Italian University Center. The techniques 
described in the present paragraph were developed and carried out jointly by the two 
laboratories. 
The RNA transfection protocol was set up in Jurkat T-cells and freshly isolated 
PBMCs using the Neon transfection system (Life Technologies). For Jurkat cells, the 
day of the transfection cells were counted and resuspended in aliquots of 5 x 106 cells 
in 100 µl of T buffer (Neon, Life Technologies) for each electroporation. 
Transfections were carried out in 100 µl tip-electrodes of the Neon transfection 
system with one 1410-V, 30-msec pulse, following the manufacturer's 
recommendations. For PBMCs, 3 x 106 cells were resuspended in 10 µl of T buffer 
for each electroporation, and transfections were carried out in 10 µl tip-electrodes of 
the Neon transfection system with one 1910-V, 30-msec pulse. The same amount of 
GFP RNA or pmaxGFP plasmid (Amaxa, LONZA) were transfected to a total of 4 µg 
for Jurkat cells and 3 µg for PBMCs. After transfections, cells were seeded in RPMI 
1640 supplemented with 10% FCS and 2 mM L-glutamine, to a final density of 1.25 
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x 106 cells/ml for Jurkat cells and 1 x 106 cells/ml for PBMCs and harvested at 
different time points. Cell viability and transfection efficiency were evaluated by flow 
cytometry. 
In order to investigate the functional interactions of Tax and p13 on the NF-κB 
pathway, the in vitro-transcribed Tax and p13GFP RNAs were transfected in freshly 
isolated PBMC and Jurkat T-cells in parallel. The day of the transfection cells were 
counted, centrifuged and resuspended in aliquots of 6 x 106 cells for each 
electroporation in 800 µl of Optimem reduced medium without phenol red (GIBCO, 
Life Technologies). Cells were incubated for 30 minutes at 37°C before transfection. 
Meanwhile, RNA was prepared for the following transfection mixtures: (1) GFP; (2) 
Tax + GFP; (3) p13GFP + GFP; (4) Tax + p13GFP. A 1-to-1 ratio for Tax and 
p13GFP RNA was maintained. A total of 6 µg RNA for Jurkat and 15 µg for PBMCs 
were transfected. Transfections were carried out in 4-mm cuvettes using the Gene 
Pulser Xcell electroporation system (Biorad) with one 500-V, 5-msec square-wave 
pulse, following the manufacturer's recommendations. After transfection, cells were 
seeded as described in Paragraph 3.1, to a final density of 1 x 106 cells/ml for Jurkat 
cells and 2 x 106 cells/ml for PBMCs and harvested after 24, 48 and 72 hours. 
 
3.5 Analysis of the NF-κB pathway by flow cytometry 
The activation of the NF-κB pathway was analyzed by flow cytometry, through the 
detection of the CD25 marker, which is a known target of NF-κB (Ballard et al., 
1988, Ruben et al., 1988). Cell activation was also monitored using the CD38 marker.  
500,000 cells were harvested 24, 48 and 72 hours after transfection, washed in PBS 
and incubated for 30 min on ice with mouse anti-human CD38-PE-Cy7 monoclonal 
antibody (1:10, in 10% FCS-PBS) (Biolegend) and mouse anti-human CD25-PE 
monoclonal antibody (1:10, in 10% FCS-PBS) (MACS, Miltenyi Biotec). CD38 (45-
kDa type II transmembrane glycoprotein) is expressed on activated T-cells, plasma 
cells, monocytes and macrophages. CD25, the interleukin-2 receptor alpha chain (IL-
2Rα), is expressed on activated T- and B-cells and at a lower level on activated 
monocytes. In order to identify the T-cell population, PBMCs were also stained with 
mouse anti-human CD3-Alexa Fluor 700 (1:50, in 10% FCS-PBS) (Biolegend). 
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Samples were analysed by flow cytometry using a BD LSRII apparatus (BD 
Biosciences) equipped with 488-nm, 633-nm, and 405 nm lasers. For each sample, 
10,000 GFP positive/transfected events were examined. Data were analyzed using the 
FACSExpress flow cytometry analysis software.  
The specific effects of the transfection on the percentage of CD25-positive cells was 
expressed as a fold change (CD25+FC) and calculated as follows: 
 
 
 
The same formula was applied to calculate the CD38+FC. 
 
3.6 Analysis of the NF-κB pathway by quantitative RT-PCR 
The activation of the NF-κB pathway was further analyzed by quantitative RT-PCR 
of 4-1BB, which codes for a co-stimulatory molecule of the tumor necrosis factor 
receptor family 9 (TNFRSF9). 4-1BB is up-regulated in HTLV-1-infected cells and 
patients and its expression is stimulated by Tax through the NF-κB pathway (Pichler 
et al., 2008). 
RNA from transfected samples was extracted using the RNeasy Micro kit (Qiagen), 
which includes a DNAase treatment step, and quantitated by spectrophotometry. 
RNA was reverse-transcribed using SuperScript II reverse transcriptase (Invitrogen) 
and random hexamers. 
The 4-1BB target gene was analysed using a PrimeTime qPCR Assays kit (IDT, 
Integrated DNA Technology). The kit contained two primers and a double-quenched 
probe for the gene of interest. The double-quenched probe was 5′ end-labeled with 
FAM, 3′ end-labeled with Iow Black FQ (IBFQ) and contained an internal ZEN 
quencher linked to a position nine base pairs downstream of the 5’ end. The shortened 
distance from FAM, combined with the 3' quencher led to an increased signal-to-
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noise ratio of the system. As an internal control, GAPDH mRNA was analyzed in 
parallel using a GAPDH PrimeTime qPCR Assays kit (IDT, Integrated DNA 
Technology). The GAPDH probe was 5′ end-labeled with HEX, 3′ end-labeled with 
IBFQ, and contained an internal ZEN quencher. 
PCR reactions were performed with a Light Cycler II 480 thermal cycler (Roche) 
using 4 µl of each diluted RT sample, 10 µl of Light Cycler 480 Master Mix (Roche), 
and 1 µl of primers and probes mix; each reaction was performed in duplicate. The 
cycling conditions comprised an initial denaturation step at 95°C for 10 minutes and 
40 cycles at 95°C for 10 seconds, 60°C for 30 seconds, 72°C for 1 second. The 
absolute quantification method was applied by using standard curves constructed 
from 5-fold serial dilutions of plasmids containing the GAPDH and 4-1BB 
amplicons.  
The absolute copy number of the 4-1BB transcript was divided by the GAPDH copy 
number to generate the normalized copy number (NCN) value. The NCN for 4-1BB 
was then divided by the fraction of GFP-positive cells measured by flow cytometry 
for each sample.  
Tax and p13 expression was verified by end-point RT-PCR using the following set of 
primers: Tax forward, 5'-CCTGTCTTTTCCAGACCCC-3'; Tax reverse, 5'-
GGGTGGCAAAAAATCACGTG-3'; p13GFP forward, 5'-
CTATGTTCGGCCCGCCT-3'; p13GFP reverse, 5'-
CTGGGTGCTCAGGTAGTGGT-3'. In order to discriminate Tax and p13 in the co-
transfected samples, the Tax primers were designed in a region downstream of the 
p13 stop codon, which is not present in the p13 expression plasmid.  
48 
 
 
49 
 
4. RESULTS 
 
4.1 Introduction of Tax and p13 into primary T-cells 
The aim of this study was to test the hypothesis that HTLV-1 Tax and p13 might act 
in concert to activate the NF-κB signal transduction pathway in normal T-cells. Tax is 
the major driver of NF-κB’s persistent activation, which promotes survival of 
infected T-cells and tumorigenesis (Sun and Yamaoka, 2005). Our previous studies 
showed that the p13 protein of HTLV-1 enhances mitochondrial ROS production, 
resulting in activation of normal T-cells (Silic-Benussi et al., 2010b). ROS constitute 
a homeostatic rheostat that controls the activity of several key pathways, including 
the NF-κB pathway. Thus, we hypothesized that ROS production mediated by p13 
could contribute to Tax’s induction of the NF-κB pathway in primary T-cells. 
To this end, we optimized a transfection protocol for primary T-cells using an 
innovative approach based on the electroporation of in vitro-transcribed RNA. The 
coding sequences of Tax and p13 were cloned into the pST1-vector (Figure 5, 
Materials and Methods, Par 3.2), which allows efficient production of highly stable in 
vitro-transcribed RNA (Holtkamp et al., 2006). Transfection of in vitro-transcribed 
RNA has emerged in recent years as a promising technique for gene transfer in cells 
refractory to standard methods of DNA transfection, including primary T-cells and 
dendritic cells (Van Tendeloo et al., 2001; Holtkamp et al., 2006; Zhao et al., 2006; 
Rowley et al., 2009). We first tested the protocol in Jurkat T-cells, which can be easily 
transfected through electroporation, and then applied it to freshly isolated peripheral 
mononuclear cells (PBMCs). 
 
4.1.2 Electroporation of in vitro-transcribed RNA in Jurkat T-cells 
Jurkat T-cells were transfected with the plasmid pmaxGFP or with GFP RNA, 
obtained from the in vitro transcription of the pST1-GFP vector (Materials and 
Methods, Par 3.2). Cell viability and the percentage of transfected cells were 
estimated through flow cytometry, by measuring the changes in side scatter 
(SSC)/forward scatter (FSC) (Figure 6, left) and GFP fluorescence (Figure 6, right), 
respectively, 24 hours after the transfection.  
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Figure 6. pmaxGFP DNA and GFP RNA transfection in Jurkat T-cells. Dot plot of the 
side/forward scatter (left) and GFP fluorescence (right) of untransfected (A), pmaxGFP - (B) and GFP 
RNA-transfected cells (C) 24 hours after electroporation. In the side/forward scatter plots (left) viable 
cells are gated and their percentage is shown. GFP-positive viable cells are indicated as green dots and 
their percentage is shown (right).  
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Figure 7 shows the analysis over time of the viability (estimated through the changes 
in the side/forward scatter) (Figure 7A) and of the transfection efficiency (Figure 7B), 
measured as percentage of GFP positive cells in the viable fraction, 24, 48 and 72 
hours after transfection. 
 
 
 
 
Figure 7. Viability and transfection efficiency of pmaxGFP- and GFP RNA- transfected Jurkat 
T-cells. A: Temporal variation in the percentage of viable cells (24, 48 and 72 hours) in untransfected 
(black line), pmaxGFP- (blue line) or GFP RNA-transfected samples (green line) Viability was 
measured from the changes in the side/forward scatter by flow cytometry. B. Percentage of GFP-
positive cells in the viable fraction 24, 48 and 72 hours after transfection of pmaxGFP (blue line) or 
GFP RNA (green line). 
 
Results showed that 24 hours after transfection, the percentage of viable cells in the 
RNA-transfected population was comparable to the untransfected sample (Figure 6A 
and C). This was also confirmed at the later time points (Figure 7A), indicating that 
RNA transfection does not significantly affect cell viability. On the contrary, 
pmaxGFP transfection dramatically reduced cell viability 24 hours after transfection 
(Figure 6B), although viability increased at the later time points, possibly due to the 
proliferation of surviving cells and loss of signal from dead cells as they were 
reduced to debris (Figure 7A).  
RNA electroporation reached a higher transfection efficiency (>90% GFP-positive 
cells), compared to DNA transfection (~70% GFP-positive cells) (Figure 7B). 
Furthermore, RNA transfection produced a more homogenous level of expression, 
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with the GFP fluorescence signal spanning one log of the intensity scale (Figure 6C), 
compared to the pmaxGFP signal that spanned over three logs (Figure 6B). These 
results confirmed that the RNA transfection technique combines a high transfection 
efficiency with low transfection-related toxicity. 
 
4.1.2 Electroporation of in vitro-transcribed RNA in normal T-cells 
The RNA transfection protocol was then tested on freshly isolated PBMCs, which are 
usually refractory to standard DNA transfection techniques. In particular, 
electroporation of DNA often results in a high toxicity combined with a low 
transfection efficiency, thus rendering subsequent analyses extremely difficult. Given 
the high transfection efficiency and good viability observed in Jurkat T-cells 
electroporated with RNA, we decided to apply this method of transfection to normal 
T-cells. 
Freshly isolated PBMCs were electroporated with pmaxGFP or in vitro-transcribed 
GFP RNA and viability and transfection efficiency were assessed, as described for 
Jurkat cells (Paragraph 4.1.1). Figure 8 shows the side scatter (SSC)/forward scatter 
(FSC) values (left) and the GFP fluorescence (right) of untransfected (Figure 8A), 
pmaxGFP- (Figure 8B) or GFP RNA-transfected PBMCs (Figure 8C), 24 hours after 
electroporation. 
As previously observed for Jurkat cells, RNA transfection yielded superior results 
compared to plasmid DNA transfection, both in terms of cell viability (48.94% RNA 
versus 8.21% DNA) and transfection efficiency (76% RNA versus 29.53% DNA) 
(Figure 8B and C). In this case, the percentage of viable cells was dramatically 
reduced in the DNA-transfected population, which also affected the transfection 
efficiency (Figure 8B). Again, RNA transfection led to a more homogenous level of 
expression, with the GFP fluorescence signal spanning one log of the intensity scale 
(Figure 8C) compared to over three logs in the DNA-transfected sample (Figure 8B). 
These results confirmed that RNA electroporation was a suitable technique for 
experiments aimed at investigating the functional interaction of Tax and p13 in the 
context of primary T-cells, a major target of viral infection in vivo.  
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Figure 8. pmaxGFP DNA and GFP RNA transfection in PBMCs. Dot plot of the side/forward 
scatter (left) and GFP fluorescence (right) of untransfected (A), pmaxGFP - (B) and GFP RNA-
transfected cells (C) 24 hours after electroporation. In the side/forward scatter plots (left) viable cells 
are gated and their percentage is shown. GFP-positive viable cells are indicated as green dots and their 
percentage is shown (right).  
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4.2 Functional interactions of Tax and p13 in T-cells 
In order to investigate the functional interactions between Tax and p13 on the NF-κB 
signal transduction pathway, freshly isolated PBMCs from healthy donors and Jurkat 
T-cells were transfected with the Tax and/or p13GFP RNA. An RNA expressing GFP 
was included in the control and in the transfections containing Tax or p13GFP alone. 
Cells were harvested at three time points (24, 48, 72 hours after transfection). The 
activation of the NF-κB pathway was evaluated by flow cytometry through the 
detection of CD25, and by quantitative RT-PCR to detect expression of the 4-1BB 
mRNA. Cell activation was monitored by the CD38 marker. 
 
4.2.1 Effects of Tax and p13 on CD25 expression 
CD25 (alfa-chain of the IL-2 receptor) is expressed on activated T- and B-cells and at 
a lower level on activated monocytes. The IL-2Rα promoter was the first shown to be 
activated by Tax in an NF-κB-dependent manner (Ballard et al., 1988, Ruben et al., 
1988). The CD3 marker was used in order to identify the T-cell population during the 
analysis. We estimated the effects on CD25 expression in the population of 
transfected cells by calculating the percentage of CD25 positive (CD25+) cells 
among the GFP-positive (GFP+) population and the percentage of CD25+ cells 
among the GFP-negative (GFP-) population of T-cells (CD3+) as described in 
Materials and Methods, Paragraph 3.5. These percentages were used to calculate the 
Fold Change in CD25+ cells (CD25+FC) (Figure 9).  
Results obtained showed that neither Tax nor p13 was sufficient to activate the NF-
κB pathway in primary T-cells (Figure 9A and B). However, the co-transfection of 
the two RNAs resulted in a synergistic activation of the pathway that was significant 
at the later time point observed (72 hours) (Figure 9A and B, p = 0,025 Student T-
test). This result was consistent with our hypothesis that p13 renders primary T-cells 
permissive for Tax-triggered activation of the NF-κB pathway. 
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Figure 9. Effects of Tax and/or p13 expression in normal T-cells. A: Temporal variation in the 
CD25+FC of normal T-cells (CD3+) transfected with GFP alone (black line), or with GFP plus Tax 
(red line), p13GFP (green line), or Tax and p13GFP RNAs (blue line). B: CD25+FC of normal T-cells 
(CD3+) transfected with GFP alone (black bar), or with GFP plus Tax (red bar), p13GFP (green bar), 
or Tax and p13GFP RNAs (blue bar) 72 hours after transfection. Mean values of 3 independent 
experiments and standard error bars are shown. The asterisks indicate a statistically significant 
difference calculated with the Student T-test.  
 
In addition to being a transcriptional target of NF-κB, CD25 is also an early marker 
of T-cell activation. To test the possible effects of Tax and p13 on T-cell activation, 
we used flow cytometry to measure the expression of CD38. CD38 is 45-kDa type II 
transmembrane glycoprotein expressed in the intermediate-late stages of T-cell 
activation, as well as in plasma cells, monocytes and macrophages. Jurkat cells, 
which exhibit a constitutively activated CD38+ phenotype, were used as a control. 
Also in this case, the CD3 marker was used in order to identify the T-cell population 
within PBMCs. The CD38+FC was calculated as described in Paragraph 3.5, 
Materials and Methods. Results of this analysis confirmed the synergy of Tax and 
p13, although the effect on normal T-cell activation was not as prominent as that 
measured with CD25 (Figure 10A and B), suggesting that, within the time frame of 
our experiments, Tax and p13 drove T-cells into an early-intermediate stage of 
activation. As expected, in Jurkat T-cells, which exhibit a constitutively CD38+ 
activated phenotype, the co-expression of Tax and/or p13 had no effect on CD38 
expression (Figure 10C).  
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Figure 10. Effects of Tax and/or p13 on CD38 expression. A: Temporal variation in the CD38+FC 
of normal T-cells (CD3+) transfected with GFP alone (black line), or with GFP plus Tax (red line), 
p13GFP (green line), or Tax and p13GFP RNAs (blue line). B: CD38+FC of normal T-cells (CD3+) 
transfected with GFP alone (black bar), or with GFP plus Tax (red bar), p13GFP (green bar), or Tax 
and p13GFP RNAs (blue bar) 72 hours after transfection. C: Temporal variation in the CD38+FC of 
Jurkat T-cells transfected with GFP alone (black line), or with GFP plus Tax (red line), p13GFP (green 
line), or Tax and p13GFP RNAs (blue line). Mean values of 3 independent experiments and standard 
error bars are shown.  
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4.2.2 Effects of Tax and p13 on 4-1BB expression 
To further investigate the effects of Tax and/or p13 on the NF-κB pathway, we 
analysed the expression of 4-1BB, a known NF-κB target gene, that is conspicuously 
activated by Tax in HTLV-1 infected cells and patients (Pichler et al., 2008). The 
expression of 4-1BB was analysed by quantitative RT-PCR as described in Paragraph 
3.6, Materials and Methods. The absolute copy number of the 4-1BB transcript was 
divided by the GAPDH copy number to generate the normalized copy number (NCN) 
value. As all transfected cells were expected to show a GFP signal, we estimated the 
effects on 4-1BB expression in the transfected cell population, by dividing the 4-1BB 
NCN for the percentage of GFP positive cells measured by flow cytometry. Figure 11 
shows the results of this analysis in PBMCs (Figure 11A) and Jurkat T-cells (Figure 
11B) 24 hours after transfection. 
 
 
 
 
Figure 11. Effects of Tax and/or p13 on the expression of 4-1BB. A: NCN of 4-1BB divided for the 
percentage of GFP-positive PBMCs transfected with GFP alone (black bar), or with GFP plus Tax (red 
bar), p13GFP (green bar), or Tax and p13GFP RNAs (blue bar) 24 hours after transfection. B: NCN of 
4-1BB divided for the percentage of GFP-positive Jurkat T-cells transfected with GFP alone (black 
bar), or with GFP plus Tax (red bar), p13GFP (green bar), or Tax and p13GFP RNAs (blue bar) 24 
hours after transfection. Mean values of 3 independent experiments and standard error bars are shown. 
The asterisk indicates a statistically significant difference calculated with the Student T-test. 
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Pilot experiments indicated that the effects on 4-1BB expression were rapid and 
transient, with expression decreasing after 24 hours (data not shown). However, 24 
hours after transfection, the level of 4-1BB expression induced by Tax and p13 co-
transfection in normal T-cells was significantly higher than in the control (Figure 
11A, p= 0,010, Student T-test), while Tax or p13 alone did not significantly affect 4-
1BB expression.  
Interestingly, in Jurkat T-cells, Tax alone was able to induce a powerful upregulation 
of 4-1BB, which was expressed at levels below the threshold of detection in the 
mock-transfected sample; p13 alone had no effect on 4-1BB expression, and co-
transfection of p13 did not significantly change the effect of Tax (Figure 11B).  
Taken together, these findings suggest that, in contrast to the well-established role of 
Tax as an activator of the NF-κB pathway in tumor cell lines (e.g. Jurkat), in the 
context of normal T-cells, the induction of NF-κB target genes requires the concerted 
action of Tax and p13.  
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5. DISCUSSION 
 
The aim of the present study was to gain insights into the interplay of HTLV-1 
proteins in the persistent activation of the NF-κB pathway, which represents a 
hallmark of HTLV-1-infected cells (Watanabe et al., 2005). According to current 
models, Tax is the major driver of the persistent activation of both the canonical and 
non-canonical NF-κB pathways, resulting in increased survival of infected T-cells 
and tumor promotion (Sun and Yamaoka, 2005). Evidence for Tax-independent 
mechanisms for NF-κB activation came from the finding that both NF-κB pathways 
are strongly activated in Tax-negative ATLL cells, which are detected in 
approximately 60% of the patients (Hironaka et al., 2004). A recent study 
demonstrated the frequent loss of miR-31 expression in ATLL. As miR-31 is a 
physiological negative regulator of the NIK kinase, its loss could contribute to the 
Tax-independent activation of NF-κB (Yamagishi et al., 2011). In addition, the viral 
protein HBZ was shown to modulate the canonical arm of the pathway by inhibiting 
the DNA binding capacity of p65 and promoting its degradation (Zhao et al., 2009). 
This inhibitory role of HBZ is of particular interest in the context of Tax-negative 
cells, which usually express HBZ protein (Fan et al., 2010; Yoshida et al., 2008). In 
this context in fact, the HBZ-mediated inhibition of the canonical NF-κB may render 
the non-canonical pathway (activated by Tax-independent mechanisms) predominant. 
In the present study, we asked whether p13 might play a role in NF-κB activation 
through its ability to modulate ROS homeostasis, which is connected to the NF-κB 
pathway through a complex reciprocal crosstalk (Morgan and Liu, 2011). p13 
activates primary T-cells in a ROS-dependent manner (Silic-Benussi et al., 2010b). 
Thus, we hypothesized that p13 could act in concert with Tax on the NF-κB pathway 
in primary T-cells.  
To this end, we optimized a transfection protocol for primary T-cells using an 
innovative approach based on the electroporation of in vitro-transcribed RNA. 
Transfection of in vitro-transcribed RNA has recently emerged as a promising 
technique for gene transfer in cells refractory to standard methods of DNA 
transfection, including primary T-cells and dendritic cells (Van Tendeloo et al., 2001; 
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Holtkamp et al., 2006; Zhao et al., 2009; Rowley et al., 2009). The RNA transfection 
protocol was first tested in Jurkat T-cells, and then applied to freshly isolated 
peripheral mononuclear cells (PBMCs). The comparison of the results obtained with 
an in vitro-transcribed RNA coding for GFP to those obtained with a plasmid coding 
for GFP revealed that the former technique yielded far better results in terms of 
percentage of transfected cells, homogeneity of transgene expression levels and cell 
viability. Building on these encouraging results, we employed RNA electroporation 
to express Tax and p13 in primary T-cells and investigated their functional interaction 
on the NF-κB pathway. 
As a readout of NF-κB activation, we measured the expression of CD25 by flow 
cytometry and 4-1BB by quantitative RT-PCR. CD25 (alfa-chain of the IL-2 
receptor) is a marker of ATLL cells and its promoter was the first shown to be 
activated by Tax in an NF-κB-dependent manner (Ballard et al., 1988; Ruben et al., 
1988). The 4-1BB gene codes for a co-stimulatory molecule of the tumor necrosis 
factor receptor family 9 (TNFRSF9). Co-stimulatory receptors of the TNFR 
superfamily are crucial mediators of proliferation and survival signals mediating T-
cell activation and maintenance of long-lived T-cell subtypes. 4-1BB is up-regulated 
in HTLV-1-infected cells and patients and its expression is stimulated by Tax through 
the NF-κB pathway (Pichler et al., 2008). The analysis of CD25 positivity and of 4-
1BB expression in Tax- and/or p13-transfected primary T-cells revealed that Tax 
alone is not sufficient to activate the expression of these NF-κB targets, suggesting 
that a further stimulus is needed to prime T-cells for Tax-activity. Our results suggest 
that this stimulus may be provided by p13. In fact, Tax and p13 expression resulted in 
a significant synergistic activation of the NF-κB pathway in primary T-cells. The 
timing of NF-κB activation was earlier for the 4-1BB mRNA (24 hours after 
transfection) than for the CD25 surface marker (72 hours after transfection). This 
could be explained by the difference in the read-out systems used (one detecting 
mRNA, the other protein levels) or to different kinetics of activation of the two NF-
κB-target genes. Interestingly, the synergistic effect of Tax and p13 was observed 
only in primary T-cells, whereas in Jurkat T-cells, Tax expression alone was 
sufficient to increase 4-1BB expression and p13 co-expression did not produce any 
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additive effect, suggesting that Jurkat T-cells are already permissive for Tax activity. 
These findings are consistent with previous reports on Tax-mediated activation of 4-
1BB expression in Jurkat T-cells (Pichler et al., 2008).  
As the CD25 is also a T-cell activation marker, the co-expression of Tax and p13 
proteins also resulted in T-cell activation. To better investigate this aspect, we also 
evaluated the effects of Tax and p13 on the expression of CD38, a type II 
transmembrane glycoprotein expressed on activated T-cells, plasma cells, monocytes 
and macrophages. Results revealed an increase in CD38 positivity upon Tax and p13 
co-expression, compared to cells expressing the individual proteins; however, the 
cooperative effect of Tax and p13 was less prominent compared to their upregulation 
of CD25 expression. A different timing of expression of the two activation markers 
could explain the difference in the magnitude of the effects observed. In Jurkat T-
cells, which exhibit a constitutively CD38-positive phenotype, the expression of Tax 
and/or p13 had no effect on CD38 expression. 
In conclusion, the experiments carried out on primary T-cells demonstrated that Tax 
is not sufficient to induce the expression of NF-κB target genes and that p13 is 
required to render T-cells permissive for Tax-activity, thus adding a further layer of 
complexity to the regulation of this pathway by HTLV-1. It is possible that 
physiological mitogenic stimulation might render T-cells permissive for Tax activity 
on the NF-κB pathway. In this scenario, p13 might be particularly relevant in resting 
T-cells, where it might contribute to NF-κB activation even in the absence of T-cell 
receptor engagement. 
Several studies demonstrated that the NF-κB pathway is involved in p53-mediated-
apoptosis (Ryan et al., 2000) and p53-p21-induced senescence (Rovillain et al., 
2011). Interestingly, Tax-mediated persistent NF-κB activation leads to cellular 
senescence in a p53-independent, p21-dependent manner (Zhi et al., 2011). These 
findings suggest that the contribution of p13 to the Tax-dependent activation of NF-
κB in primary T-cells could result in different outcomes on cell fate depending on the 
magnitude and duration of the activation of the pathway: on one hand, persistent NF-
κB activation could promote cell survival and the initial steps of leukemogenesis; on 
the other hand, an excessive level of NF-κB activation could promote cell death or 
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senescence of infected cells. In this last case, p13 might act as a viral tumor 
suppressor that reduces proliferation and favors cell death or growth arrest of Tax-
expressing cells. Interestingly, Tax-induced senescence can be counteracted by the 
HBZ viral protein, which down-regulates NF-κB (Zhi et al., 2011), suggesting that it 
would be of particular interest to investigate the combined effects of Tax, p13 and 
HBZ expression on the NF-κB pathway and on the fate of primary T-cells.  
Current studies are aimed at verifying the ROS-dependence of the synergistic effect 
of Tax and p13 by using ROS scavengers and ROS-inducing agents. In addition, we 
will test the validity of the functional interaction of Tax and p13 in the context of the 
complete HTLV-1 genome. To this end, we will compare the effects of wild type 
HTLV-1 and a p13-knock-out HTLV-1 molecular clone on NF-κB activation. These 
experiments will be carried out in primary T-cells as well as in primary dendritic 
cells, which have recently emerged as an important target of the virus in vivo (Jones 
et al., 2008). 
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